/**
 * Topics Content - Konu Ã–zetleri Veri DosyasÄ±
 * KapsamlÄ± konu anlatÄ±mlarÄ±
 */

const topicsData = [
    {
        id: 1,
        category: "bakteriyoloji",
        title: "Bacillus anthracis",
        subtitle: "Åarbon (Antraks) Etkeni",
        summary: "Gram pozitif, spor oluÅŸturan, aerob, hareketsiz, kapsÃ¼llÃ¼ basil. Biyolojik silah potansiyeli olan, Ã¼Ã§ klinik formda (deri, solunum, gastrointestinal) hastalÄ±k yapan Ã¶nemli bir patojendir.",
        tags: ["Gram Pozitif", "Spor Yapan", "Biyolojik Silah", "Toksin", "Zoonoz"],
        sections: [
            {
                title: "Genel Ã–zellikler",
                icon: "fas fa-microscope",
                content: `
                    <p><strong>Bacillus anthracis</strong>, Bacillus cinsinin en Ã¶nemli insan patojenidir. Gram pozitif, aerob, hareketsiz, bÃ¼yÃ¼k (1-1.5 Ã— 3-10 Î¼m), uÃ§larÄ± kÃ¶ÅŸeli basil morfolojisindedir.</p>
                    
                    <div class="highlight-box">
                        <p class="highlight-box__title">TanÄ±mlayÄ±cÄ± Ã–zellikler</p>
                        <p class="highlight-box__content">
                            <strong>"Bambu KamÄ±ÅŸÄ±" veya "Vagon Dizisi"</strong> gÃ¶rÃ¼nÃ¼mÃ¼ - Zincirlerde uÃ§ uca dizilmiÅŸ basiller karakteristiktir. Boyama ile metakromatik granÃ¼ller gÃ¶rÃ¼lebilir.
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Spor:</b> Merkezi veya submerkezi, hÃ¼creyi ÅŸiÅŸirmez (subterminal), eliptik</li>
                        <li class="feature-item"><b>KapsÃ¼l:</b> Poly-D-glutamik asit (protein yapÄ±da, antifagositik) - pXO2 plazmidi kodlar</li>
                        <li class="feature-item"><b>Hareket:</b> HAREKETSÄ°Z (diÄŸer Bacillus tÃ¼rlerinden ayÄ±rÄ±cÄ±!)</li>
                        <li class="feature-item"><b>Hemoliz:</b> Non-hemolitik veya zayÄ±f hemolitik (B. cereus gÃ¼Ã§lÃ¼ Î²-hemolitik)</li>
                        <li class="feature-item"><b>Katalaz:</b> Pozitif</li>
                    </ul>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Dikkat:</strong> B. anthracis HAREKETSÄ°Z, NON-HEMOLÄ°TÄ°K'tir. B. cereus ise hareketli ve Î²-hemolitik. Bu Ã¶zellikler ayÄ±rÄ±cÄ± tanÄ±da kritiktir!</p>
                    </div>
                `
            },
            {
                title: "VirÃ¼lans FaktÃ¶rleri",
                icon: "fas fa-biohazard",
                content: `
                    <p>B. anthracis'in virÃ¼lansÄ± <strong>iki bÃ¼yÃ¼k plazmide</strong> baÄŸlÄ±dÄ±r. Her iki plazmid de tam virÃ¼lans iÃ§in gereklidir:</p>

                    <table class="article-table">
                        <tr>
                            <th>Plazmid</th>
                            <th>KodladÄ±ÄŸÄ±</th>
                            <th>Fonksiyon</th>
                        </tr>
                        <tr>
                            <td><b>pXO1</b> (182 kb)</td>
                            <td>Toksin genleri (pagA, lef, cya)</td>
                            <td>Antraks toksini Ã¼retimi</td>
                        </tr>
                        <tr>
                            <td><b>pXO2</b> (96 kb)</td>
                            <td>KapsÃ¼l genleri (capBCAD)</td>
                            <td>Antifagositik kapsÃ¼l</td>
                        </tr>
                    </table>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antraks Toksini (A-B Toksin Modeli)</h4>
                        <p>ÃœÃ§ ayrÄ± protein birlikte Ã§alÄ±ÅŸarak toksin etkisi oluÅŸturur:</p>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Protective Antigen (PA):</b> B komponenti - HÃ¼cre yÃ¼zeyine baÄŸlanÄ±r, diÄŸer iki komponentin giriÅŸini saÄŸlar</li>
                            <li class="feature-item"><b>Edema Factor (EF):</b> Adenilat siklaz aktivitesi - cAMPâ†‘ â†’ Masif Ã¶dem</li>
                            <li class="feature-item"><b>Lethal Factor (LF):</b> Ã‡inko metaloproteaz - MAPK yolaÄŸÄ±nÄ± keser â†’ Makrofaj Ã¶lÃ¼mÃ¼, sitokin fÄ±rtÄ±nasÄ±</li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Toksin KombinasyonlarÄ±</p>
                        <p class="highlight-box__content">
                            <strong>PA + EF = Ã–dem Toksini</strong> (lokal Ã¶dem)<br>
                            <strong>PA + LF = Letal Toksin</strong> (ÅŸok, Ã¶lÃ¼m)
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>SÄ±nav Notu:</strong> Antraks toksin genleri <strong>plazmid (pXO1)</strong> kaynaklÄ±dÄ±r, FAJ KAYNAKLI DEÄÄ°LDÄ°R! Difteri, kolera, shiga toksinleri faj kaynaklÄ±yken, antraks toksini plazmid kodlar.</p>
                    </div>
                `
            },
            {
                title: "Klinik Formlar",
                icon: "fas fa-user-injured",
                content: `
                    <p>Antraks Ã¼Ã§ ana klinik formda karÅŸÄ±mÄ±za Ã§Ä±kar. BulaÅŸ yoluna gÃ¶re form deÄŸiÅŸir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">1. Deri Antraksi (%95)</h4>
                        <ul class="feature-list">
                            <li class="feature-item">En sÄ±k form, en iyi prognoz (%1 mortalite tedavisiz, %20 tedavisiz)</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> SporlarÄ±n deriye temasÄ± (kesik, sÄ±yrÄ±k)</li>
                            <li class="feature-item"><b>Lezyon:</b> PapÃ¼l â†’ VezikÃ¼l â†’ <b>ESKÄ°RAR (siyah kabuk)</b> - AÄŸrÄ±sÄ±z!</li>
                            <li class="feature-item"><b>"Malignant pustule"</b> veya <b>"Charbon" (kÃ¶mÃ¼r)</b> adÄ± lezyondan gelir</li>
                            <li class="feature-item">Ã‡evresinde jelatinÃ¶z Ã¶dem (toksin etkisi)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">2. Solunum (Pulmoner/Ä°nhalasyon) Antraksi</h4>
                        <ul class="feature-list">
                            <li class="feature-item">En aÄŸÄ±r form, %90-100 mortalite (geÃ§ tanÄ±)</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Spor inhalasyonu (yÃ¼n, deri iÅŸÃ§ileri - "Woolsorter's disease")</li>
                            <li class="feature-item"><b>BaÅŸlangÄ±Ã§:</b> Grip benzeri (ateÅŸ, Ã¶ksÃ¼rÃ¼k, miyalji)</li>
                            <li class="feature-item"><b>Ä°lerleme:</b> Hemorajik mediastinit, <b>mediastinal geniÅŸleme (PA akciÄŸer grafisi)</b></li>
                            <li class="feature-item"><b>Son dÃ¶nem:</b> Dispne, siyanoz, ÅŸok, Ã¶lÃ¼m (24-36 saat iÃ§inde)</li>
                        </ul>
                        <div class="alert-box">
                            <span class="alert-box__icon">ğŸš¨</span>
                            <p class="alert-box__text">AkciÄŸer grafisinde <strong>mediastinal geniÅŸleme</strong> gÃ¶rÃ¼lmesi pulmoner antraksÄ± dÃ¼ÅŸÃ¼ndÃ¼rÃ¼r! (Hemorajik lenfadenit)</p>
                        </div>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">3. Gastrointestinal Antraks</h4>
                        <ul class="feature-list">
                            <li class="feature-item">Nadir, %25-60 mortalite</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Kontamine et tÃ¼ketimi (az piÅŸmiÅŸ)</li>
                            <li class="feature-item"><b>Orofaringeal form:</b> BoÄŸazda Ã¼lser, Ã¶dem, lenfadenopati</li>
                            <li class="feature-item"><b>Ä°ntestinal form:</b> KarÄ±n aÄŸrÄ±sÄ±, kanlÄ± ishal, asit, ÅŸok</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">4. Enjeksiyon Antraksi (Yeni tanÄ±mlanan)</h4>
                        <ul class="feature-list">
                            <li class="feature-item">IV uyuÅŸturucu kullanÄ±cÄ±larÄ±nda (kontamine eroin)</li>
                            <li class="feature-item">Derin yumuÅŸak doku enfeksiyonu, nekrotizan fasiit benzeri</li>
                            <li class="feature-item">Avrupa'da salgÄ±nlar bildirilmiÅŸ</li>
                        </ul>
                    </div>
                `
            },
            {
                title: "Laboratuvar TanÄ±sÄ±",
                icon: "fas fa-flask",
                content: `
                    <p>TanÄ± klinik ÅŸÃ¼phe ile baÅŸlar. <strong>BiyogÃ¼venlik dÃ¼zey 3 (BSL-3)</strong> laboratuvar ÅŸartlarÄ± Ã¶nerilir ancak rutin iÅŸlemler BSL-2'de yapÄ±labilir.</p>

                    <table class="article-table">
                        <tr>
                            <th>YÃ¶ntem</th>
                            <th>Bulgu</th>
                            <th>Not</th>
                        </tr>
                        <tr>
                            <td>Gram boyama</td>
                            <td>Gram (+) bÃ¼yÃ¼k basil, zincir</td>
                            <td>"Bambu kamÄ±ÅŸÄ±" gÃ¶rÃ¼nÃ¼mÃ¼</td>
                        </tr>
                        <tr>
                            <td>PolisÃ¶m kapsÃ¼l boyama</td>
                            <td>India ink, M'Fadyean</td>
                            <td>Pembe kapsÃ¼l (metilen mavisi)</td>
                        </tr>
                        <tr>
                            <td>KÃ¼ltÃ¼r</td>
                            <td>Koyun kanlÄ± agar, 37Â°C</td>
                            <td>"Medusa baÅŸÄ±" koloni</td>
                        </tr>
                        <tr>
                            <td>Motilite</td>
                            <td>Hareketsiz</td>
                            <td>Kritik ayÄ±rÄ±cÄ± Ã¶zellik</td>
                        </tr>
                        <tr>
                            <td>PCR</td>
                            <td>pXO1, pXO2 genleri</td>
                            <td>HÄ±zlÄ± ve spesifik</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Koloni Morfolojisi</p>
                        <p class="highlight-box__content">
                            <strong>"Medusa baÅŸÄ±"</strong> veya <strong>"Aslan yelesi"</strong> gÃ¶rÃ¼nÃ¼mÃ¼ - Koloniden dÄ±ÅŸa doÄŸru uzanan, kÄ±vrÄ±k zincirler halinde oluÅŸum. Koloni kenarlarÄ± dÃ¼zensiz, mat, yapÄ±ÅŸkan olmayan, gri-beyaz renkte.
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Gamma faj lizis testi:</b> B. anthracis'i lizogenik faj tanÄ±r (pozitif = B. anthracis)</li>
                        <li class="feature-item"><b>String of pearls testi:</b> Penisilin varlÄ±ÄŸÄ±nda sferik formlar ("inci dizisi")</li>
                        <li class="feature-item"><b>Bicarbonate agar:</b> COâ‚‚ varlÄ±ÄŸÄ±nda kapsÃ¼l Ã¼retimi artar (mukoid koloni)</li>
                    </ul>
                `
            },
            {
                title: "Tedavi ve Profilaksi",
                icon: "fas fa-pills",
                content: `
                    <p>Tedavi hÄ±zlÄ± baÅŸlamalÄ±dÄ±r. <strong>Antibiyotik + Antitoksin</strong> kombinasyonu aÄŸÄ±r vakalarda kullanÄ±lÄ±r.</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antibiyotik Tedavisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°lk seÃ§enek:</b> Siprofloksasin veya Doksisiklin (ampirik)</li>
                            <li class="feature-item"><b>Sistemik hastalÄ±k:</b> IV Siprofloksasin + Meropenem + Linezolid (Ã¼Ã§lÃ¼ kombinasyon)</li>
                            <li class="feature-item"><b>Penisilin:</b> DuyarlÄ±lÄ±k kanÄ±tlanÄ±rsa kullanÄ±labilir (Î²-laktamaz nadir)</li>
                            <li class="feature-item"><b>SÃ¼re:</b> Deri antraksi 7-10 gÃ¼n, sistemik 60 gÃ¼n (spor germinasyonu)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antitoksin Tedavisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Raxibacumab:</b> Anti-PA monoklonal antikor, FDA onaylÄ±</li>
                            <li class="feature-item"><b>Obiltoxaximab:</b> Anti-PA monoklonal antikor</li>
                            <li class="feature-item"><b>Antraks immÃ¼n globÃ¼lin (AIG):</b> Ä°nsan kaynaklÄ± poliklonal</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>AVA (Anthrax Vaccine Adsorbed):</b> PA iÃ§eren aselÃ¼ler aÅŸÄ±</li>
                            <li class="feature-item"><b>Endikasyon:</b> YÃ¼ksek riskli meslek gruplarÄ±, askeri personel</li>
                            <li class="feature-item"><b>Åema:</b> 0, 1, 6 ay + yÄ±llÄ±k rapel</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Post-exposure profilaksi:</strong> 60 gÃ¼n antibiyotik + 3 doz aÅŸÄ± (0, 2, 4 hafta). Sporlar akciÄŸerlerde haftalarca canlÄ± kalÄ±p germinasyon yapabilir!</p>
                    </div>
                `
            },
            {
                title: "Epidemiyoloji ve BiyoterÃ¶rizm",
                icon: "fas fa-globe",
                content: `
                    <p>B. anthracis <strong>CDC Kategori A biyoterÃ¶rizm ajanÄ±dÄ±r</strong>. SporlarÄ±n stabilite, Ã¼retim kolaylÄ±ÄŸÄ± ve aerosol yayÄ±lÄ±m potansiyeli kritik tehdit oluÅŸturur.</p>

                    <ul class="feature-list">
                        <li class="feature-item"><b>DoÄŸal bulaÅŸ:</b> Hayvan temasÄ±, hayvansal Ã¼rÃ¼nler (deri, yÃ¼n, kemik unu)</li>
                        <li class="feature-item"><b>Endemik bÃ¶lgeler:</b> TÃ¼rkiye, Orta Asya, Afrika, GÃ¼ney Amerika</li>
                        <li class="feature-item"><b>Risk meslekler:</b> Veteriner, kasap, Ã§iftÃ§i, deri/yÃ¼n iÅŸÃ§isi</li>
                        <li class="feature-item"><b>2001 ABD saldÄ±rÄ±sÄ±:</b> Mektupla yayÄ±lan sporlar, 22 vaka, 5 Ã¶lÃ¼m</li>
                    </ul>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Spor DayanÄ±klÄ±lÄ±ÄŸÄ±</p>
                        <p class="highlight-box__content">
                            Antraks sporlarÄ± toprakta <strong>40+ yÄ±l</strong> canlÄ± kalabilir. Kaynatma, Ã§oÄŸu dezenfektan etkisizdir. <strong>Otoklav (121Â°C, 15 dk)</strong> veya <strong>sporisidal ajanlar</strong> gerekir.
                        </p>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">AyÄ±rÄ±cÄ± Ã–zellikler Ã–zeti</p>
                        <p class="mnemonic-box__text">HNK</p>
                        <p class="mnemonic-box__hint">Hareketsiz - Non-hemolitik - KapsÃ¼llÃ¼</p>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Noktalar",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">TUS/Yeterlilik Klasikleri</p>
                        <p class="highlight-box__content">
                            1. Antraks toksini <strong>PLAZMID (pXO1)</strong> kaynaklÄ±dÄ±r, faj deÄŸil!<br>
                            2. B. anthracis <strong>HAREKETSÄ°Z</strong> (diÄŸer Bacillus hareketli)<br>
                            3. Deri lezyonu <strong>AÄRISIZ</strong>, siyah eskar<br>
                            4. Pulmoner antraksta <strong>mediastinal geniÅŸleme</strong><br>
                            5. KapsÃ¼l <strong>protein yapÄ±da</strong> (poli-D-glutamik asit), polisakkarit deÄŸil!
                        </p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Ã–zellik</th>
                            <th>B. anthracis</th>
                            <th>B. cereus</th>
                        </tr>
                        <tr>
                            <td>Hareket</td>
                            <td><b>Hareketsiz</b></td>
                            <td>Hareketli</td>
                        </tr>
                        <tr>
                            <td>Hemoliz</td>
                            <td>Non-hemolitik</td>
                            <td><b>Î²-hemolitik</b></td>
                        </tr>
                        <tr>
                            <td>KapsÃ¼l</td>
                            <td><b>Var</b></td>
                            <td>Yok</td>
                        </tr>
                        <tr>
                            <td>Gamma faj</td>
                            <td>DuyarlÄ±</td>
                            <td>DirenÃ§li</td>
                        </tr>
                        <tr>
                            <td>Penisilin</td>
                            <td>DuyarlÄ±</td>
                            <td>DirenÃ§li</td>
                        </tr>
                    </table>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Soru tipi:</b> "Spor oluÅŸturan, hareketsiz, kapsÃ¼llÃ¼ patojen?" â†’ B. anthracis</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Siyah eskar + jelatinÃ¶z Ã¶dem?" â†’ Deri antraksi</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Mediastinal geniÅŸleme + solunum sÄ±kÄ±ntÄ±sÄ±?" â†’ Pulmoner antraks</li>
                        <li class="feature-item"><b>Soru tipi:</b> "pXO1 ve pXO2 plazmidleri hangi bakteride?" â†’ B. anthracis</li>
                    </ul>
                `
            }
        ]
    },
    {
        id: 2,
        category: "viroloji",
        title: "OrtomiksovirÃ¼sler",
        subtitle: "Ä°nfluenza (Grip) VirÃ¼sleri",
        summary: "Segmentli, negatif iplikli RNA genomuna sahip, zarflÄ± virÃ¼slerdir. Antijenik shift ve drift mekanizmalarÄ±yla epidemi ve pandemilere neden olurlar. Ä°nfluenza A, B ve C tÃ¼rlerini iÃ§erir.",
        tags: ["RNA VirÃ¼sÃ¼", "Segmentli Genom", "ZarflÄ±", "Ä°nfluenza", "Pandemi", "Antijenik Varyasyon"],
        sections: [
            {
                title: "Genel Ã–zellikler",
                icon: "fas fa-virus",
                content: `
                    <p><strong>OrtomiksovirÃ¼sler</strong> (Orthomyxoviridae), solunum yolu enfeksiyonlarÄ±nÄ±n en Ã¶nemli viral etkenlerinden biridir. "Ortho" (dÃ¼z) ve "myxo" (mukus) kelimelerinden tÃ¼retilmiÅŸtir - mukus zarÄ±na afinitelerini yansÄ±tÄ±r.</p>
                    
                    <div class="highlight-box">
                        <p class="highlight-box__title">TanÄ±mlayÄ±cÄ± Ã–zellikler</p>
                        <p class="highlight-box__content">
                            <strong>Segmentli Genom:</strong> 7-8 segmentli negatif polariteli ssRNA genomu. Bu yapÄ± <strong>genetik reassortment (antijenik shift)</strong> iÃ§in temel oluÅŸturur ve pandemi potansiyeli yaratÄ±r.
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Genom:</b> (-) ssRNA, segmentli (Ä°nfluenza A ve B: 8 segment, Ä°nfluenza C: 7 segment)</li>
                        <li class="feature-item"><b>Boyut:</b> 80-120 nm, pleomorfik (yuvarlak veya filamentÃ¶z)</li>
                        <li class="feature-item"><b>Zarf:</b> Var - Konak hÃ¼cre membranÄ±ndan kÃ¶ken alÄ±r</li>
                        <li class="feature-item"><b>Replikasyon:</b> <strong>Ã‡EKIRDEKTE</strong> (RNA virÃ¼sleri iÃ§in istisna!)</li>
                        <li class="feature-item"><b>Simetri:</b> Helikal nÃ¼kleokapsid</li>
                    </ul>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Dikkat:</strong> Ä°nfluenza virÃ¼sÃ¼ Ã§ekirdekte replike olan nadir RNA virÃ¼slerindendir! DiÄŸerleri: RetrovirÃ¼sler, BornavirÃ¼s, Hepatit D. Ã‡oÄŸu RNA virÃ¼sÃ¼ sitoplazmada Ã§oÄŸalÄ±r.</p>
                    </div>
                `
            },
            {
                title: "YapÄ±sal Proteinler ve Antijenik YapÄ±",
                icon: "fas fa-dna",
                content: `
                    <p>VirÃ¼s yÃ¼zeyinde iki kritik glikoprotein bulunur. Bunlar hem virÃ¼lans hem de aÅŸÄ±/ilaÃ§ hedefi olarak Ã¶nemlidir:</p>

                    <table class="article-table">
                        <tr>
                            <th>Protein</th>
                            <th>Fonksiyon</th>
                            <th>Klinik Ã–nemi</th>
                        </tr>
                        <tr>
                            <td><b>HemaglÃ¼tinin (HA)</b></td>
                            <td>Sialik asit reseptÃ¶rÃ¼ne baÄŸlanma, membran fÃ¼zyonu</td>
                            <td>NÃ¶tralizan antikor hedefi, H1-H18 alt tipleri</td>
                        </tr>
                        <tr>
                            <td><b>NÃ¶raminidaz (NA)</b></td>
                            <td>Sialik asidi keser, virÃ¼s salÄ±nÄ±mÄ±, mukus penetrasyonu</td>
                            <td>Antiviral hedef (Oseltamivir), N1-N11 alt tipleri</td>
                        </tr>
                        <tr>
                            <td><b>M1 (Matriks)</b></td>
                            <td>Kapsid yapÄ±sÄ±, virÃ¼s tomurcuklanmasÄ±</td>
                            <td>En bol protein, tip spesifik antijen</td>
                        </tr>
                        <tr>
                            <td><b>M2 (Ä°yon kanalÄ±)</b></td>
                            <td>Proton kanalÄ±, uncoating iÃ§in pH dÃ¼ÅŸÃ¼rme</td>
                            <td>Amantadin hedefi (sadece Ä°nfluenza A)</td>
                        </tr>
                        <tr>
                            <td><b>NP (NÃ¼kleoprotein)</b></td>
                            <td>RNA'yÄ± sarar, tip spesifik</td>
                            <td>A, B, C ayrÄ±mÄ±nda kullanÄ±lÄ±r</td>
                        </tr>
                    </table>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Ä°nfluenza TÃ¼rleri KarÅŸÄ±laÅŸtÄ±rmasÄ±</h4>
                        <table class="article-table">
                            <tr>
                                <th>Ã–zellik</th>
                                <th>Ä°nfluenza A</th>
                                <th>Ä°nfluenza B</th>
                                <th>Ä°nfluenza C</th>
                            </tr>
                            <tr>
                                <td>Konak</td>
                                <td>Ä°nsan, kuÅŸ, domuz, at, deniz memelileri</td>
                                <td>Sadece insan</td>
                                <td>Ä°nsan, domuz</td>
                            </tr>
                            <tr>
                                <td>Segment sayÄ±sÄ±</td>
                                <td>8</td>
                                <td>8</td>
                                <td>7</td>
                            </tr>
                            <tr>
                                <td>Antijenik shift</td>
                                <td><b>VAR (Pandemi!)</b></td>
                                <td>Yok</td>
                                <td>Yok</td>
                            </tr>
                            <tr>
                                <td>HastalÄ±k ÅŸiddeti</td>
                                <td>AÄŸÄ±r</td>
                                <td>Orta</td>
                                <td>Hafif</td>
                            </tr>
                            <tr>
                                <td>M2 proteini</td>
                                <td>Var</td>
                                <td>Yok (NB var)</td>
                                <td>Yok</td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Antijen AdlandÄ±rma Sistemi</p>
                        <p class="highlight-box__content">
                            <strong>A/California/7/2009 (H1N1)</strong><br>
                            A = Tip | California = Ä°zolasyon yeri | 7 = SuÅŸ no | 2009 = YÄ±l | (H1N1) = Alt tip
                        </p>
                    </div>
                `
            },
            {
                title: "Antijenik Varyasyon MekanizmalarÄ±",
                icon: "fas fa-random",
                content: `
                    <p>Ä°nfluenza virÃ¼sÃ¼nÃ¼n sÃ¼rekli deÄŸiÅŸimi, tekrarlayan enfeksiyonlarÄ±n ve aÅŸÄ± gÃ¼ncellemelerinin temel nedenidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">1. Antijenik Drift (Kayma)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Mekanizma:</b> RNA polimerazÄ±n dÃ¼zeltme (proofreading) aktivitesinin olmamasÄ± â†’ Nokta mutasyonlar birikimi</li>
                            <li class="feature-item"><b>Etkilenen genler:</b> Ã–zellikle HA ve NA genleri</li>
                            <li class="feature-item"><b>SonuÃ§:</b> Mevcut antikorlardan kÄ±smi kaÃ§Ä±ÅŸ</li>
                            <li class="feature-item"><b>Epidemiyoloji:</b> YÄ±llÄ±k <strong>EPÄ°DEMÄ°LER</strong></li>
                            <li class="feature-item"><b>GÃ¶rÃ¼ldÃ¼ÄŸÃ¼ tipler:</b> Ä°nfluenza A ve B</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">2. Antijenik Shift (SÄ±Ã§rama)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Mekanizma:</b> FarklÄ± tÃ¼rlerden gelen virÃ¼slerin <strong>genetik reassortment</strong>'Ä± (segment deÄŸiÅŸimi)</li>
                            <li class="feature-item"><b>Gereksinim:</b> AynÄ± hÃ¼crede iki farklÄ± virÃ¼sÃ¼n ko-enfeksiyonu</li>
                            <li class="feature-item"><b>SonuÃ§:</b> Tamamen yeni HA veya NA alt tipi â†’ Toplumda baÄŸÄ±ÅŸÄ±klÄ±k yok</li>
                            <li class="feature-item"><b>Epidemiyoloji:</b> <strong>PANDEMÄ°LER</strong></li>
                            <li class="feature-item"><b>GÃ¶rÃ¼ldÃ¼ÄŸÃ¼ tipler:</b> <strong>SADECE Ä°nfluenza A</strong> (zoonotik rezervuar nedeniyle)</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>SÄ±nav Notu:</strong> Shift = Segment deÄŸiÅŸimi = Sadece A = Pandemi<br>
                        Drift = Nokta mutasyon = A ve B = Epidemi<br>
                        <strong>"Shift" kelimesinde "S" harfi = "Segment" ve "Sadece A"</strong></p>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Domuz "KarÄ±ÅŸtÄ±rma KabÄ±" (Mixing Vessel)</p>
                        <p class="highlight-box__content">
                            Domuz solunum epiteli hem Î±2,3 (kuÅŸ tipi) hem Î±2,6 (insan tipi) sialik asit reseptÃ¶rÃ¼ taÅŸÄ±r. Bu nedenle kuÅŸ ve insan virÃ¼sleri domuzda aynÄ± anda Ã§oÄŸalÄ±p reassortment yapabilir â†’ Yeni pandemik suÅŸlar!
                        </p>
                    </div>
                `
            },
            {
                title: "Replikasyon DÃ¶ngÃ¼sÃ¼",
                icon: "fas fa-sync-alt",
                content: `
                    <p>Ä°nfluenza virÃ¼sÃ¼nÃ¼n yaÅŸam dÃ¶ngÃ¼sÃ¼, antiviral ilaÃ§larÄ±n hedef noktalarÄ±nÄ± anlamak iÃ§in kritiktir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Replikasyon BasamaklarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>1. Tutunma:</b> HA â†’ Sialik asit reseptÃ¶rÃ¼ (Î±2,6 insan, Î±2,3 kuÅŸ)</li>
                            <li class="feature-item"><b>2. GiriÅŸ:</b> ReseptÃ¶r aracÄ±lÄ± endositoz</li>
                            <li class="feature-item"><b>3. Uncoating:</b> M2 iyon kanalÄ± â†’ Endozom asidifikasyonu â†’ Viral RNA salÄ±nÄ±mÄ±</li>
                            <li class="feature-item"><b>4. Ã‡ekirdek transportu:</b> vRNP kompleksleri Ã§ekirdeÄŸe taÅŸÄ±nÄ±r</li>
                            <li class="feature-item"><b>5. Transkripsiyon/Replikasyon:</b> Viral RNA polimeraz (PB1, PB2, PA) Ã§ekirdekte Ã§alÄ±ÅŸÄ±r</li>
                            <li class="feature-item"><b>6. Protein sentezi:</b> mRNA â†’ Sitoplazmada translasyon</li>
                            <li class="feature-item"><b>7. Montaj:</b> YÃ¼zey proteinleri (HA, NA) Golgi'de glikozillenir</li>
                            <li class="feature-item"><b>8. Tomurcuklanma:</b> HÃ¼cre zarÄ±ndan Ã§Ä±kÄ±ÅŸ</li>
                            <li class="feature-item"><b>9. SalÄ±nÄ±m:</b> NA sialik asidi keser â†’ VirÃ¼s serbest kalÄ±r</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Basamak</th>
                            <th>Antiviral Ä°laÃ§</th>
                            <th>Not</th>
                        </tr>
                        <tr>
                            <td>Uncoating (M2)</td>
                            <td>Amantadin, Rimantadin</td>
                            <td>Sadece A, yaygÄ±n direnÃ§</td>
                        </tr>
                        <tr>
                            <td>SalÄ±nÄ±m (NA)</td>
                            <td>Oseltamivir, Zanamivir</td>
                            <td>A ve B, ilk seÃ§enek</td>
                        </tr>
                        <tr>
                            <td>Cap-snatching</td>
                            <td>Baloxavir marboxil</td>
                            <td>Yeni, tek doz</td>
                        </tr>
                    </table>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Cap-Snatching:</strong> Ä°nfluenza, konak mRNA'larÄ±ndan "cap" yapÄ±sÄ±nÄ± Ã§alar (cap-snatching). Bu viral mRNA sentezi iÃ§in gereklidir ve Ã§ekirdekte replikasyonun nedenlerinden biridir!</p>
                    </div>
                `
            },
            {
                title: "Klinik Tablolar",
                icon: "fas fa-user-injured",
                content: `
                    <p>Ä°nfluenza enfeksiyonu asemptomatikten Ã¶lÃ¼mcÃ¼le kadar geniÅŸ bir spektrumda seyredebilir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Klasik Ä°nfluenza (Grip)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°nkÃ¼basyon:</b> 1-4 gÃ¼n (ortalama 2 gÃ¼n)</li>
                            <li class="feature-item"><b>BaÅŸlangÄ±Ã§:</b> ANÄ°, yÃ¼ksek ateÅŸ (39-41Â°C), titreme</li>
                            <li class="feature-item"><b>Sistemik:</b> Åiddetli miyalji, artralji, baÅŸ aÄŸrÄ±sÄ±, halsizlik, iÅŸtahsÄ±zlÄ±k</li>
                            <li class="feature-item"><b>Solunum:</b> Kuru Ã¶ksÃ¼rÃ¼k, boÄŸaz aÄŸrÄ±sÄ±, rinore, gÃ¶z yaÅŸarmasÄ±</li>
                            <li class="feature-item"><b>SÃ¼re:</b> AteÅŸ 3-5 gÃ¼n, Ã¶ksÃ¼rÃ¼k 2-3 hafta sÃ¼rebilir</li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Grip vs. SoÄŸuk AlgÄ±nlÄ±ÄŸÄ±</p>
                        <p class="highlight-box__content">
                            <strong>Grip:</strong> Ani baÅŸlangÄ±Ã§, yÃ¼ksek ateÅŸ, ÅŸiddetli miyalji, yataÄŸa dÃ¼ÅŸÃ¼rÃ¼r<br>
                            <strong>SoÄŸuk algÄ±nlÄ±ÄŸÄ±:</strong> YavaÅŸ baÅŸlangÄ±Ã§, hafif ateÅŸ, rinore Ã¶n planda, gÃ¼nlÃ¼k aktivite devam eder
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Komplikasyonlar</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Primer viral pnÃ¶moni:</b> Nadir ama Ã¶lÃ¼mcÃ¼l, bilateral interstisyel infiltrasyon, ARDS geliÅŸebilir</li>
                            <li class="feature-item"><b>Sekonder bakteriyel pnÃ¶moni:</b> En sÄ±k komplikasyon. Etkenler: <strong>S. pneumoniae, S. aureus, H. influenzae</strong></li>
                            <li class="feature-item"><b>Reye sendromu:</b> Aspirinle birlikte â†’ Ensefalopati + KaraciÄŸer yaÄŸlanmasÄ± (Ã§ocuklarda)</li>
                            <li class="feature-item"><b>Miyokardit/Perikardit:</b> Nadir</li>
                            <li class="feature-item"><b>Ensefalit:</b> Nadir</li>
                            <li class="feature-item"><b>Guillain-BarrÃ© sendromu:</b> Post-enfeksiyÃ¶z</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>Reye Sendromu:</strong> 18 yaÅŸ altÄ±nda grip veya suÃ§iÃ§eÄŸi + Aspirin kullanÄ±mÄ± â†’ Akut ensefalopati + MikrovezikÃ¼ler karaciÄŸer yaÄŸlanmasÄ±. <strong>Ã‡ocuklarda aspirin kontrendike!</strong></p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">YÃ¼ksek Risk GruplarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item">65 yaÅŸ Ã¼stÃ¼, 2 yaÅŸ altÄ±</li>
                            <li class="feature-item">Gebeler (Ã¶zellikle 2. ve 3. trimester)</li>
                            <li class="feature-item">Kronik hastalÄ±klar (KOAH, astÄ±m, DM, kalp hastalÄ±ÄŸÄ±)</li>
                            <li class="feature-item">Ä°mmÃ¼nsÃ¼presifler</li>
                            <li class="feature-item">Morbid obezite (BMI â‰¥40)</li>
                            <li class="feature-item">BakÄ±mevi sakinleri</li>
                        </ul>
                    </div>
                `
            },
            {
                title: "Laboratuvar TanÄ±sÄ±",
                icon: "fas fa-flask",
                content: `
                    <p>TanÄ± klinik olarak konabilir ancak epidemiyolojik sÃ¼rveyans ve antiviral tedavi kararÄ± iÃ§in laboratuvar doÄŸrulamasÄ± Ã¶nemlidir:</p>

                    <table class="article-table">
                        <tr>
                            <th>YÃ¶ntem</th>
                            <th>Avantaj</th>
                            <th>Dezavantaj</th>
                        </tr>
                        <tr>
                            <td><b>HÄ±zlÄ± Antijen Testi (RIDT)</b></td>
                            <td>15-30 dk sonuÃ§, ucuz, kolay</td>
                            <td>DÃ¼ÅŸÃ¼k duyarlÄ±lÄ±k (%50-70)</td>
                        </tr>
                        <tr>
                            <td><b>RT-PCR</b></td>
                            <td>AltÄ±n standart, yÃ¼ksek duyarlÄ±lÄ±k/Ã¶zgÃ¼llÃ¼k, tiplendirme</td>
                            <td>PahalÄ±, uzun sÃ¼re, ekipman gerektirir</td>
                        </tr>
                        <tr>
                            <td><b>DFA (Direkt Floresan Antikor)</b></td>
                            <td>BirkaÃ§ saat, panel tarama</td>
                            <td>Deneyimli personel gerektirir</td>
                        </tr>
                        <tr>
                            <td><b>Viral KÃ¼ltÃ¼r</b></td>
                            <td>Referans standart, izolasyon</td>
                            <td>3-7 gÃ¼n, rutin tanÄ±da kullanÄ±lmaz</td>
                        </tr>
                        <tr>
                            <td><b>Seroloji</b></td>
                            <td>Retrospektif tanÄ±, epidemiyolojik Ã§alÄ±ÅŸmalar</td>
                            <td>Akut tanÄ±da faydasÄ±z (4 kat titre artÄ±ÅŸÄ± gerekir)</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Ã–rnek Alma</p>
                        <p class="highlight-box__content">
                            <strong>Optimal Ã¶rnek:</strong> Nazofaringeal sÃ¼rÃ¼ntÃ¼ veya aspirat<br>
                            <strong>Zamanlama:</strong> Semptom baÅŸlangÄ±cÄ±ndan sonraki ilk 3-4 gÃ¼n (viral yÃ¼k en yÃ¼ksek)<br>
                            <strong>Transport:</strong> Viral transport besiyerinde, +4Â°C'de
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>HemaglÃ¼tinasyon Ä°nhibisyon (HAI):</b> Serotiplendirme iÃ§in referans yÃ¶ntem</li>
                        <li class="feature-item"><b>KÃ¼ltÃ¼r ortamÄ±:</b> MDCK hÃ¼creleri (kÃ¶pek bÃ¶brek), embriyonlu yumurta</li>
                        <li class="feature-item"><b>Sitopatik etki:</b> Belirgin deÄŸil, hemaglÃ¼tinasyon ile tespit edilir</li>
                    </ul>
                `
            },
            {
                title: "Tedavi",
                icon: "fas fa-pills",
                content: `
                    <p>Antiviral tedavi <strong>semptom baÅŸlangÄ±cÄ±ndan sonraki 48 saat iÃ§inde</strong> baÅŸlanÄ±rsa en etkilidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">NÃ¶raminidaz Ä°nhibitÃ¶rleri (Ä°lk SeÃ§enek)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Oseltamivir (Tamiflu):</b> Oral, 75 mg 2x1, 5 gÃ¼n. Ã‡ocuklarda ve gebelerde kullanÄ±labilir</li>
                            <li class="feature-item"><b>Zanamivir (Relenza):</b> Ä°nhaler, 10 mg 2x1, 5 gÃ¼n. AstÄ±m/KOAH'ta dikkatli</li>
                            <li class="feature-item"><b>Peramivir:</b> IV, tek doz. Hospitalize hastalarda</li>
                            <li class="feature-item"><b>Etki:</b> Ä°nfluenza A ve B'ye etkili</li>
                            <li class="feature-item"><b>Mekanizma:</b> NA enzimini inhibe eder â†’ VirÃ¼s hÃ¼creden Ã§Ä±kamaz</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">M2 Ä°nhibitÃ¶rleri (ArtÄ±k Ã–nerilmez)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Amantadin, Rimantadin:</b> Sadece Ä°nfluenza A'ya etkili</li>
                            <li class="feature-item"><b>Mekanizma:</b> M2 iyon kanalÄ±nÄ± bloke eder â†’ Uncoating engellenir</li>
                            <li class="feature-item"><b>Sorun:</b> YaygÄ±n direnÃ§ (>%99), Ä°nfluenza B'ye etkisiz</li>
                            <li class="feature-item"><b>Yan etkiler:</b> SSS toksisitesi (amantadin)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Yeni Antiviraller</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Baloxavir marboxil (Xofluza):</b> Cap-baÄŸÄ±mlÄ± endonÃ¼kleaz inhibitÃ¶rÃ¼. Tek doz oral. A ve B'ye etkili</li>
                            <li class="feature-item"><b>Favipiravir:</b> RNA polimeraz inhibitÃ¶rÃ¼, geniÅŸ spektrum</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Tedavi EndikasyonlarÄ±:</strong><br>
                        â€¢ Hospitalize hastalar<br>
                        â€¢ AÄŸÄ±r veya komplike grip<br>
                        â€¢ YÃ¼ksek risk gruplarÄ±<br>
                        â€¢ 48 saat iÃ§inde baÅŸvuran tÃ¼m doÄŸrulanmÄ±ÅŸ vakalar</p>
                    </div>
                `
            },
            {
                title: "Korunma ve AÅŸÄ±lama",
                icon: "fas fa-shield-virus",
                content: `
                    <p>Ä°nfluenza aÅŸÄ±sÄ± her yÄ±l gÃ¼ncellenir ve en etkili korunma yÃ¶ntemidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ± Tipleri</h4>
                        <table class="article-table">
                            <tr>
                                <th>AÅŸÄ± Tipi</th>
                                <th>Ã–zellik</th>
                                <th>Uygulama</th>
                            </tr>
                            <tr>
                                <td><b>IIV (Ä°naktive)</b></td>
                                <td>Ã–lÃ¼ virÃ¼s, en yaygÄ±n</td>
                                <td>IM, 6 ay Ã¼stÃ¼ herkese</td>
                            </tr>
                            <tr>
                                <td><b>LAIV (CanlÄ± AtenÃ¼e)</b></td>
                                <td>SoÄŸuÄŸa adapte, zayÄ±flatÄ±lmÄ±ÅŸ</td>
                                <td>Ä°ntranazal, 2-49 yaÅŸ saÄŸlÄ±klÄ± bireyler</td>
                            </tr>
                            <tr>
                                <td><b>Rekombinant (RIV)</b></td>
                                <td>Yumurta iÃ§ermez</td>
                                <td>Yumurta alerjisinde</td>
                            </tr>
                            <tr>
                                <td><b>YÃ¼ksek Doz IIV</b></td>
                                <td>4x antijen iÃ§erir</td>
                                <td>65 yaÅŸ Ã¼stÃ¼</td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">AÅŸÄ± Ä°Ã§eriÄŸi (2024-2025 Ã–rnek)</p>
                        <p class="highlight-box__content">
                            <strong>Kuadrivalan:</strong> 2 Ä°nfluenza A (H1N1 ve H3N2) + 2 Ä°nfluenza B (Victoria ve Yamagata soylarÄ±)<br>
                            Her yÄ±l DSÃ– Ã¶nerisiyle gÃ¼ncellenir (Kuzey yarÄ±mkÃ¼re: Åubat, GÃ¼ney: EylÃ¼l)
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ± KontrendikasyonlarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item">AÅŸÄ± bileÅŸenlerine ciddi alerjik reaksiyon Ã¶ykÃ¼sÃ¼</li>
                            <li class="feature-item"><b>LAIV kontrendike:</b> Gebeler, immÃ¼nsÃ¼presifler, 2 yaÅŸ altÄ±, astÄ±mlÄ±lar, aspirin kullanan Ã§ocuklar</li>
                            <li class="feature-item">AÄŸÄ±r yumurta alerjisinde: Rekombinant aÅŸÄ± veya tÄ±bbi gÃ¶zetimde IIV</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Kemoprofilaksi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°ndikasyon:</b> AÅŸÄ± kontrendike veya yetersiz kaldÄ±ÄŸÄ±nda temas sonrasÄ±</li>
                            <li class="feature-item"><b>Ä°laÃ§:</b> Oseltamivir 75 mg 1x1, 7-10 gÃ¼n veya temas sÃ¼resince</li>
                            <li class="feature-item"><b>Zanamivir:</b> 10 mg 1x1 inhaler, alternatif</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>LAIV (CanlÄ± aÅŸÄ±):</strong> CanlÄ± virÃ¼s iÃ§erdiÄŸinden immÃ¼nsÃ¼presif hastalara, gebelere ve 2 yaÅŸ altÄ±na <strong>KESÄ°NLÄ°KLE YAPILMAZ!</strong> Ä°naktif aÅŸÄ± (IIV) bu gruplarda tercih edilir.</p>
                    </div>
                `
            },
            {
                title: "Epidemiyoloji ve Pandemiler",
                icon: "fas fa-globe",
                content: `
                    <p>Ä°nfluenza, insanlÄ±k tarihinin en yÄ±kÄ±cÄ± pandemilerine neden olmuÅŸtur:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Ã–nemli Pandemiler</h4>
                        <table class="article-table">
                            <tr>
                                <th>Pandemi</th>
                                <th>YÄ±l</th>
                                <th>Alt Tip</th>
                                <th>Ã–lÃ¼m</th>
                            </tr>
                            <tr>
                                <td><b>Ä°spanyol Gribi</b></td>
                                <td>1918-1919</td>
                                <td>H1N1</td>
                                <td>50-100 milyon</td>
                            </tr>
                            <tr>
                                <td><b>Asya Gribi</b></td>
                                <td>1957-1958</td>
                                <td>H2N2</td>
                                <td>1-2 milyon</td>
                            </tr>
                            <tr>
                                <td><b>Hong Kong Gribi</b></td>
                                <td>1968-1969</td>
                                <td>H3N2</td>
                                <td>1 milyon</td>
                            </tr>
                            <tr>
                                <td><b>Domuz Gribi</b></td>
                                <td>2009-2010</td>
                                <td>H1N1pdm09</td>
                                <td>~284.000</td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">KuÅŸ Gribi Tehdidi</p>
                        <p class="highlight-box__content">
                            <strong>H5N1:</strong> YÃ¼ksek mortalite (%60), sÄ±nÄ±rlÄ± insan-insan bulaÅŸÄ±<br>
                            <strong>H7N9:</strong> Ã‡in'de sporadik vakalar, pandemi potansiyeli<br>
                            KuÅŸ â†’ Ä°nsan bulaÅŸÄ± olur ancak etkin insan-insan bulaÅŸÄ± iÃ§in mutasyon gerekir
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Mevsimsel daÄŸÄ±lÄ±m:</b> Kuzey yarÄ±mkÃ¼rede KasÄ±m-Mart, gÃ¼neyde MayÄ±s-EylÃ¼l</li>
                        <li class="feature-item"><b>BulaÅŸ:</b> DamlacÄ±k (>5 Î¼m, 1-2 m), aerosol (<5 Î¼m), temas</li>
                        <li class="feature-item"><b>BulaÅŸtÄ±rÄ±cÄ±lÄ±k:</b> Semptom baÅŸlangÄ±cÄ±ndan 1 gÃ¼n Ã¶nce - 5-7 gÃ¼n sonra</li>
                        <li class="feature-item"><b>R0 (Mevsimsel):</b> 1.2-1.4</li>
                        <li class="feature-item"><b>R0 (Pandemik):</b> 1.5-2.5</li>
                    </ul>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">Pandemi ÅartlarÄ±</p>
                        <p class="mnemonic-box__text">YEB</p>
                        <p class="mnemonic-box__hint">Yeni alt tip - Etkin insan-insan bulaÅŸÄ± - BaÄŸÄ±ÅŸÄ±klÄ±k yok</p>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Noktalar",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">TUS/Yeterlilik Klasikleri</p>
                        <p class="highlight-box__content">
                            1. <strong>Segmentli genom</strong> â†’ Reassortment â†’ Shift â†’ Pandemi<br>
                            2. <strong>Ã‡ekirdekte replikasyon</strong> yapan RNA virÃ¼sÃ¼!<br>
                            3. Shift <strong>sadece Ä°nfluenza A</strong>'da gÃ¶rÃ¼lÃ¼r<br>
                            4. <strong>Domuz = Mixing vessel</strong> (karÄ±ÅŸtÄ±rma kabÄ±)<br>
                            5. M2 proteini <strong>sadece Ä°nfluenza A</strong>'da var<br>
                            6. <strong>Reye sendromu:</strong> Grip/SuÃ§iÃ§eÄŸi + Aspirin (Ã§ocuk)<br>
                            7. Sekonder bakteriyel pnÃ¶moni: <strong>S. aureus, S. pneumoniae</strong>
                        </p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>KarÅŸÄ±laÅŸtÄ±rma</th>
                            <th>Drift</th>
                            <th>Shift</th>
                        </tr>
                        <tr>
                            <td>Mekanizma</td>
                            <td>Nokta mutasyon</td>
                            <td>Reassortment</td>
                        </tr>
                        <tr>
                            <td>HÄ±z</td>
                            <td>Kademeli</td>
                            <td>Ani</td>
                        </tr>
                        <tr>
                            <td>SonuÃ§</td>
                            <td>Epidemi</td>
                            <td><b>Pandemi</b></td>
                        </tr>
                        <tr>
                            <td>Tipler</td>
                            <td>A ve B</td>
                            <td><b>Sadece A</b></td>
                        </tr>
                    </table>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Soru tipi:</b> "Segmentli genom, zarflÄ±, Ã§ekirdekte Ã§oÄŸalan RNA virÃ¼sÃ¼?" â†’ Ä°nfluenza</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Grip sonrasÄ± S. aureus pnÃ¶monisi?" â†’ Sekonder bakteriyel pnÃ¶moni</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Antijenik shift ile pandemi yapan virÃ¼s?" â†’ Ä°nfluenza A</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Amantadin hangi virÃ¼se etkili?" â†’ Sadece Ä°nfluenza A (M2 proteini)</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Oseltamivir hedefi?" â†’ NÃ¶raminidaz</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Ã‡ocukta grip + aspirin sonrasÄ± ensefalopati?" â†’ Reye sendromu</li>
                    </ul>
                `
            }
        ]
    },
    {
        id: 3,
        category: "bakteriyoloji",
        title: "Streptococcus agalactiae",
        subtitle: "Grup B Streptokok (GBS)",
        summary: "Î²-hemolitik, Lancefield Grup B antijeni taÅŸÄ±yan, Gram pozitif kok. YenidoÄŸan sepsis ve menenjitinin en sÄ±k etkeni olup, gebelikte tarama ve intrapartum profilaksi ile Ã¶nlenebilir.",
        tags: ["Gram Pozitif", "Î²-Hemolitik", "YenidoÄŸan Sepsis", "GBS", "CAMP Testi"],
        sections: [
            {
                title: "Genel Ã–zellikler",
                icon: "fas fa-microscope",
                content: `
                    <p><strong>Streptococcus agalactiae</strong>, Lancefield sÄ±nÄ±flamasÄ±nda <strong>Grup B</strong> antijeni taÅŸÄ±yan, Î²-hemolitik streptokoktur. Ã–zellikle yenidoÄŸan enfeksiyonlarÄ±ndaki rolÃ¼ nedeniyle klinik Ã¶nemi bÃ¼yÃ¼ktÃ¼r.</p>
                    
                    <div class="highlight-box">
                        <p class="highlight-box__title">TanÄ±mlayÄ±cÄ± Ã–zellikler</p>
                        <p class="highlight-box__content">
                            <strong>CAMP Testi Pozitif:</strong> S. aureus'un Î²-hemolizini ile sinerjistik etki â†’ Ok ucu ÅŸeklinde hemoliz. GBS tanÄ±sÄ±nda patognomonik test!
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Morfoloji:</b> Gram pozitif kok, zincir oluÅŸturur</li>
                        <li class="feature-item"><b>Hemoliz:</b> Î²-hemolitik (tam hemoliz, berrak zon)</li>
                        <li class="feature-item"><b>Lancefield grubu:</b> Grup B (hÃ¼cre duvarÄ± karbonhidrat antijeni)</li>
                        <li class="feature-item"><b>Katalaz:</b> Negatif (tÃ¼m streptokoklar gibi)</li>
                        <li class="feature-item"><b>Oksidaz:</b> Negatif</li>
                        <li class="feature-item"><b>FakÃ¼ltatif anaerob:</b> Evet</li>
                    </ul>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Kolonizasyon:</strong> SaÄŸlÄ±klÄ± kadÄ±nlarÄ±n %15-30'unda vajinal ve rektal kolonizasyon bulunur. Asemptomatik taÅŸÄ±yÄ±cÄ±lÄ±k klinik aÃ§Ä±dan Ã¶nemlidir!</p>
                    </div>
                `
            },
            {
                title: "VirÃ¼lans FaktÃ¶rleri",
                icon: "fas fa-biohazard",
                content: `
                    <p>GBS'nin patogenezi Ã§eÅŸitli virÃ¼lans faktÃ¶rlerine baÄŸlÄ±dÄ±r:</p>

                    <table class="article-table">
                        <tr>
                            <th>VirÃ¼lans FaktÃ¶rÃ¼</th>
                            <th>Fonksiyon</th>
                            <th>Klinik Ã–nemi</th>
                        </tr>
                        <tr>
                            <td><b>Polisakkarit KapsÃ¼l</b></td>
                            <td>Antifagositik, kompleman inhibisyonu</td>
                            <td>Ana virÃ¼lans faktÃ¶rÃ¼, serotiplendirmede kullanÄ±lÄ±r (Ia, Ib, II-IX)</td>
                        </tr>
                        <tr>
                            <td><b>C5a Peptidaz</b></td>
                            <td>Kompleman C5a'yÄ± parÃ§alar</td>
                            <td>NÃ¶trofil kemotaksisini engeller</td>
                        </tr>
                        <tr>
                            <td><b>Î²-Hemolizin/Sitoalizin</b></td>
                            <td>HÃ¼cre lizisi, pigment Ã¼retimi</td>
                            <td>Doku hasarÄ±, CAMP faktÃ¶rÃ¼</td>
                        </tr>
                        <tr>
                            <td><b>Sialik Asit</b></td>
                            <td>MolekÃ¼ler benzerlik (mimetizm)</td>
                            <td>Ä°mmÃ¼n kaÃ§Ä±ÅŸ</td>
                        </tr>
                        <tr>
                            <td><b>Pili (Fimbriae)</b></td>
                            <td>Epitel hÃ¼crelere tutunma</td>
                            <td>Kolonizasyon</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Serotiplendirme</p>
                        <p class="highlight-box__content">
                            KapsÃ¼ler polisakkarite gÃ¶re 10 serotip: <strong>Ia, Ib, II, III, IV, V, VI, VII, VIII, IX</strong><br>
                            <strong>Serotip III:</strong> YenidoÄŸan menenjitinin en sÄ±k etkeni!<br>
                            <strong>Serotip V:</strong> EriÅŸkin invaziv enfeksiyonlarda sÄ±k
                        </p>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>CAMP FaktÃ¶rÃ¼:</strong> GBS'nin Ã¼rettiÄŸi protein, S. aureus'un sfingomyelinaz C'si (Î²-toksin) ile sinerjistik etki gÃ¶sterir. Bu etkileÅŸim CAMP testinin temelini oluÅŸturur.</p>
                    </div>
                `
            },
            {
                title: "Klinik Tablolar - YenidoÄŸan",
                icon: "fas fa-baby",
                content: `
                    <p>GBS, yenidoÄŸan dÃ¶neminde iki farklÄ± klinik tablo ile karÅŸÄ±mÄ±za Ã§Ä±kar:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">1. Erken BaÅŸlangÄ±Ã§lÄ± HastalÄ±k (Early-Onset Disease)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Zamanlama:</b> DoÄŸumdan sonraki ilk 7 gÃ¼n iÃ§inde (genellikle ilk 24-48 saat)</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Vertikal (doÄŸum kanalÄ±ndan geÃ§iÅŸ sÄ±rasÄ±nda)</li>
                            <li class="feature-item"><b>Klinik:</b> Sepsis, pnÃ¶moni, menenjit</li>
                            <li class="feature-item"><b>Mortalite:</b> %5-10 (tedavi ile)</li>
                            <li class="feature-item"><b>Risk faktÃ¶rleri:</b> PrematÃ¼rite, uzamÄ±ÅŸ membran rÃ¼ptÃ¼rÃ¼ (>18 saat), maternal GBS kolonizasyonu, intrapartum ateÅŸ</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">2. GeÃ§ BaÅŸlangÄ±Ã§lÄ± HastalÄ±k (Late-Onset Disease)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Zamanlama:</b> 7 gÃ¼n - 3 ay arasÄ±</li>
                            <li class="feature-item"><b>BulaÅŸ:</b> Horizontal (hastane, toplum, anne)</li>
                            <li class="feature-item"><b>Klinik:</b> <strong>Menenjit</strong> daha sÄ±k (serotip III)</li>
                            <li class="feature-item"><b>Mortalite:</b> %2-6</li>
                            <li class="feature-item"><b>Sekel:</b> Ä°ÅŸitme kaybÄ±, nÃ¶rolojik hasar (%25-50)</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>Kritik:</strong> GBS, yenidoÄŸan dÃ¶neminde <strong>bakteriyel sepsis ve menenjitin en sÄ±k etkenidir!</strong> Erken tanÄ± ve tedavi hayat kurtarÄ±cÄ±dÄ±r.</p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Ã–zellik</th>
                            <th>Erken BaÅŸlangÄ±Ã§</th>
                            <th>GeÃ§ BaÅŸlangÄ±Ã§</th>
                        </tr>
                        <tr>
                            <td>Zaman</td>
                            <td>0-7 gÃ¼n</td>
                            <td>7 gÃ¼n - 3 ay</td>
                        </tr>
                        <tr>
                            <td>BulaÅŸ</td>
                            <td>Vertikal</td>
                            <td>Horizontal</td>
                        </tr>
                        <tr>
                            <td>Ana klinik</td>
                            <td>Sepsis, pnÃ¶moni</td>
                            <td><b>Menenjit</b></td>
                        </tr>
                        <tr>
                            <td>Ã–nlenebilir mi?</td>
                            <td><b>Evet (IAP)</b></td>
                            <td>HayÄ±r</td>
                        </tr>
                    </table>
                `
            },
            {
                title: "Klinik Tablolar - EriÅŸkin ve Gebeler",
                icon: "fas fa-user-injured",
                content: `
                    <p>GBS sadece yenidoÄŸanlarda deÄŸil, gebelerde ve eriÅŸkinlerde de ciddi enfeksiyonlara neden olabilir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Gebelerde GBS EnfeksiyonlarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Asemptomatik bakteriÃ¼ri:</b> En sÄ±k, tarama ile saptanÄ±r</li>
                            <li class="feature-item"><b>Ãœriner sistem enfeksiyonu:</b> Sistit, piyelonefrit</li>
                            <li class="feature-item"><b>Koryoamnionit:</b> Ä°ntrauterin enfeksiyon</li>
                            <li class="feature-item"><b>Endometrit:</b> Postpartum</li>
                            <li class="feature-item"><b>Bakteriyemi:</b> Nadiren</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">EriÅŸkinlerde (Gebe Olmayan)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Risk gruplarÄ±:</b> Diyabet, kanser, karaciÄŸer hastalÄ±ÄŸÄ±, immÃ¼nsÃ¼presyon, >65 yaÅŸ</li>
                            <li class="feature-item"><b>Deri ve yumuÅŸak doku:</b> SelÃ¼lit, apse, nekrotizan fasiit (nadir)</li>
                            <li class="feature-item"><b>Kemik ve eklem:</b> Osteomiyelit, septik artrit</li>
                            <li class="feature-item"><b>Bakteriyemi:</b> Primer veya sekonder</li>
                            <li class="feature-item"><b>PnÃ¶moni:</b> Ã–zellikle yaÅŸlÄ±larda</li>
                            <li class="feature-item"><b>Endokardit:</b> Nadir ama ciddi</li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Artmakta Olan Sorun</p>
                        <p class="highlight-box__content">
                            EriÅŸkin invaziv GBS enfeksiyonlarÄ± son yÄ±llarda artmaktadÄ±r. Ã–zellikle <strong>diyabetik ayak enfeksiyonlarÄ±</strong> ve <strong>yaÅŸlÄ±larda bakteriyemi</strong> Ã¶nemli klinik tablolardÄ±r.
                        </p>
                    </div>
                `
            },
            {
                title: "Laboratuvar TanÄ±sÄ±",
                icon: "fas fa-flask",
                content: `
                    <p>GBS tanÄ±sÄ±nda Ã§eÅŸitli laboratuvar yÃ¶ntemleri kullanÄ±lÄ±r:</p>

                    <table class="article-table">
                        <tr>
                            <th>YÃ¶ntem</th>
                            <th>SonuÃ§</th>
                            <th>KullanÄ±m</th>
                        </tr>
                        <tr>
                            <td><b>Gram boyama</b></td>
                            <td>Gram (+) koklar, zincir</td>
                            <td>HÄ±zlÄ± Ã¶n tanÄ±</td>
                        </tr>
                        <tr>
                            <td><b>KanlÄ± agar kÃ¼ltÃ¼rÃ¼</b></td>
                            <td>Î²-hemoliz (dar zon)</td>
                            <td>AltÄ±n standart</td>
                        </tr>
                        <tr>
                            <td><b>CAMP testi</b></td>
                            <td><strong>POZÄ°TÄ°F</strong> (ok ucu hemoliz)</td>
                            <td>TanÄ±sal, S. aureus ile</td>
                        </tr>
                        <tr>
                            <td><b>HipÃ¼rat hidrolizi</b></td>
                            <td><strong>POZÄ°TÄ°F</strong></td>
                            <td>DiÄŸer Î²-hemolitiklerden ayÄ±rÄ±m</td>
                        </tr>
                        <tr>
                            <td><b>Basitrasin duyarlÄ±lÄ±ÄŸÄ±</b></td>
                            <td><strong>DÄ°RENÃ‡LÄ°</strong></td>
                            <td>GAS'tan ayÄ±rÄ±m (GAS duyarlÄ±)</td>
                        </tr>
                        <tr>
                            <td><b>Lateks aglÃ¼tinasyon</b></td>
                            <td>Grup B antijeni (+)</td>
                            <td>HÄ±zlÄ± gruplama</td>
                        </tr>
                        <tr>
                            <td><b>Kromojenik agar</b></td>
                            <td>Renkli koloniler</td>
                            <td>Tarama kolaylÄ±ÄŸÄ±</td>
                        </tr>
                        <tr>
                            <td><b>PCR (NAAT)</b></td>
                            <td>GBS DNA</td>
                            <td>HÄ±zlÄ± intrapartum tarama</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">CAMP Testi ProsedÃ¼rÃ¼</p>
                        <p class="highlight-box__content">
                            Koyun kanlÄ± agarda S. aureus Ã§izgisine dik olarak GBS Ã§izilir. 37Â°C'de inkÃ¼basyondan sonra kesiÅŸim noktasÄ±nda <strong>ok baÅŸÄ± ÅŸeklinde</strong> geniÅŸlemiÅŸ hemoliz zonu gÃ¶rÃ¼lÃ¼r. Bu sinerjistik hemoliz GBS iÃ§in karakteristiktir.
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Tarama Ã–rneÄŸi:</strong> Vajinal ve rektal sÃ¼rÃ¼ntÃ¼ birlikte alÄ±nmalÄ± (vajino-rektal sÃ¼rÃ¼ntÃ¼). Tek baÅŸÄ±na vajinal sÃ¼rÃ¼ntÃ¼ kolonizasyonun %10-20'sini kaÃ§Ä±rÄ±r!</p>
                    </div>
                `
            },
            {
                title: "Tedavi",
                icon: "fas fa-pills",
                content: `
                    <p>GBS enfeksiyonlarÄ±nda <strong>penisilin</strong> ilk seÃ§enek tedavidir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Antibiyotik Tedavisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Ä°lk seÃ§enek:</b> Penisilin G (IV)</li>
                            <li class="feature-item"><b>Alternatif:</b> Ampisilin</li>
                            <li class="feature-item"><b>Penisilin alerjisi:</b> Sefazolin (dÃ¼ÅŸÃ¼k risk), Klindamisin veya Vankomisin (yÃ¼ksek risk)</li>
                            <li class="feature-item"><b>Menenjit:</b> YÃ¼ksek doz Penisilin G veya Ampisilin (Â± Gentamisin sinerjisi)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">DirenÃ§ Durumu</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Penisilin:</b> DirenÃ§ bildirilmemiÅŸ (MIC artÄ±ÅŸÄ± nadiren)</li>
                            <li class="feature-item"><b>Eritromisin:</b> %25-35 direnÃ§</li>
                            <li class="feature-item"><b>Klindamisin:</b> %15-25 direnÃ§</li>
                            <li class="feature-item"><b>Vankomisin:</b> DirenÃ§ yok</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Klinik Tablo</th>
                            <th>Tedavi</th>
                            <th>SÃ¼re</th>
                        </tr>
                        <tr>
                            <td>Neonatal sepsis</td>
                            <td>Ampisilin + Gentamisin</td>
                            <td>10-14 gÃ¼n</td>
                        </tr>
                        <tr>
                            <td>Neonatal menenjit</td>
                            <td>Ampisilin (yÃ¼ksek doz)</td>
                            <td>Minimum 14-21 gÃ¼n</td>
                        </tr>
                        <tr>
                            <td>EriÅŸkin bakteriyemi</td>
                            <td>Penisilin G</td>
                            <td>10-14 gÃ¼n</td>
                        </tr>
                        <tr>
                            <td>Osteomiyelit</td>
                            <td>Penisilin G</td>
                            <td>4-6 hafta</td>
                        </tr>
                    </table>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Ã–nemli:</strong> Penisilin alerjisi Ã¶ykÃ¼sÃ¼ varsa, alerji tipi sorgulanmalÄ±. IgE aracÄ±lÄ± (anafilaksi) deÄŸilse sefazolin gÃ¼venle kullanÄ±labilir. Belirsiz veya ciddi alerjide duyarlÄ±lÄ±k testine gÃ¶re klindamisin veya vankomisin tercih edilir.</p>
                    </div>
                `
            },
            {
                title: "Korunma - Ä°ntrapartum Antibiyotik Profilaksisi (IAP)",
                icon: "fas fa-shield-virus",
                content: `
                    <p>Erken baÅŸlangÄ±Ã§lÄ± GBS hastalÄ±ÄŸÄ±, <strong>intrapartum antibiyotik profilaksisi (IAP)</strong> ile Ã¶nlenebilir:</p>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Tarama Stratejisi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Zamanlama:</b> 36-37. gebelik haftasÄ±nda (eski: 35-37 hafta)</li>
                            <li class="feature-item"><b>Ã–rnek:</b> Vajino-rektal sÃ¼rÃ¼ntÃ¼</li>
                            <li class="feature-item"><b>YÃ¶ntem:</b> KÃ¼ltÃ¼r (altÄ±n standart) veya NAAT (hÄ±zlÄ± sonuÃ§)</li>
                            <li class="feature-item"><b>SonuÃ§ geÃ§erliliÄŸi:</b> 5 hafta</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">IAP EndikasyonlarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Pozitif GBS taramasÄ±</b> (en sÄ±k endikasyon)</li>
                            <li class="feature-item"><b>GBS bakteriÃ¼risi</b> mevcut gebelikte (herhangi bir dÃ¶nemde)</li>
                            <li class="feature-item"><b>Ã–nceki bebekte invaziv GBS hastalÄ±ÄŸÄ±</b></li>
                            <li class="feature-item"><b>Bilinmeyen GBS durumu</b> + risk faktÃ¶rÃ¼:
                                <ul>
                                    <li>- <37 hafta doÄŸum</li>
                                    <li>- Membran rÃ¼ptÃ¼rÃ¼nden â‰¥18 saat geÃ§mesi</li>
                                    <li>- Ä°ntrapartum ateÅŸ â‰¥38Â°C</li>
                                </ul>
                            </li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">IAP Rejimi</p>
                        <p class="highlight-box__content">
                            <strong>Ä°lk seÃ§enek:</strong> Penisilin G 5 milyon Ãœ IV yÃ¼kleme, ardÄ±ndan 2.5-3 milyon Ãœ her 4 saatte doÄŸuma kadar<br>
                            <strong>Alternatif:</strong> Ampisilin 2 g IV yÃ¼kleme, ardÄ±ndan 1 g her 4 saatte<br>
                            <strong>Penisilin alerjisi:</strong> Sefazolin, klindamisin veya vankomisin<br>
                            <strong>Optimal sÃ¼re:</strong> DoÄŸumdan en az 4 saat Ã¶nce baÅŸlanmalÄ±
                        </p>
                    </div>

                    <div class="alert-box alert-box--success">
                        <span class="alert-box__icon">âœ…</span>
                        <p class="alert-box__text"><strong>BaÅŸarÄ±:</strong> IAP uygulamasÄ± ile erken baÅŸlangÄ±Ã§lÄ± GBS hastalÄ±ÄŸÄ± insidansÄ± %80 azalmÄ±ÅŸtÄ±r (1990'lardan bu yana). Ancak geÃ§ baÅŸlangÄ±Ã§lÄ± hastalÄ±k Ã¼zerine etkisi yoktur.</p>
                    </div>
                `
            },
            {
                title: "Epidemiyoloji",
                icon: "fas fa-globe",
                content: `
                    <p>GBS dÃ¼nya genelinde Ã¶nemli bir perinatal patojendir:</p>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Kolonizasyon oranÄ±:</b> Gebe kadÄ±nlarÄ±n %15-30'u</li>
                        <li class="feature-item"><b>Vertikal geÃ§iÅŸ:</b> Kolonize annelerin bebeklerinin %50'si kolonize olur</li>
                        <li class="feature-item"><b>HastalÄ±k geliÅŸimi:</b> Kolonize bebeklerin %1-2'sinde</li>
                        <li class="feature-item"><b>Erken baÅŸlangÄ±Ã§lÄ± insidans:</b> 0.2-0.5/1000 canlÄ± doÄŸum (IAP sonrasÄ±)</li>
                        <li class="feature-item"><b>GeÃ§ baÅŸlangÄ±Ã§lÄ± insidans:</b> 0.3-0.4/1000 canlÄ± doÄŸum</li>
                    </ul>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Risk FaktÃ¶rleri</p>
                        <p class="highlight-box__content">
                            <strong>YenidoÄŸan iÃ§in:</strong> PrematÃ¼rite, dÃ¼ÅŸÃ¼k doÄŸum aÄŸÄ±rlÄ±ÄŸÄ±, uzamÄ±ÅŸ membran rÃ¼ptÃ¼rÃ¼, maternal ateÅŸ, yÃ¼ksek maternal kolonizasyon<br>
                            <strong>EriÅŸkin iÃ§in:</strong> Diyabet, obezite, malignite, immÃ¼nsÃ¼presyon, ileri yaÅŸ
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">AÅŸÄ± GeliÅŸtirme Ã‡alÄ±ÅŸmalarÄ±</h4>
                        <ul class="feature-list">
                            <li class="feature-item">KapsÃ¼ler polisakkarit konjuge aÅŸÄ±lar deneme aÅŸamasÄ±nda</li>
                            <li class="feature-item">Hedef: Gebelikte maternal aÅŸÄ±lama â†’ Transplasental antikor transferi</li>
                            <li class="feature-item">Hem erken hem geÃ§ baÅŸlangÄ±Ã§lÄ± hastalÄ±ÄŸÄ± Ã¶nleme potansiyeli</li>
                        </ul>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">GBS Ã–zet</p>
                        <p class="mnemonic-box__text">CAMPing with Baby</p>
                        <p class="mnemonic-box__hint">CAMP (+), Baby (yenidoÄŸan en sÄ±k etken)</p>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Noktalar",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">TUS/Yeterlilik Klasikleri</p>
                        <p class="highlight-box__content">
                            1. <strong>YenidoÄŸan sepsis ve menenjitinin EN SIK etkeni</strong><br>
                            2. <strong>CAMP testi POZÄ°TÄ°F</strong> (ok ucu hemoliz)<br>
                            3. <strong>HipÃ¼rat hidrolizi POZÄ°TÄ°F</strong><br>
                            4. <strong>Basitrasin DÄ°RENÃ‡LÄ°</strong> (GAS duyarlÄ±)<br>
                            5. <strong>Serotip III</strong> = Menenjit<br>
                            6. Tarama: <strong>36-37. hafta</strong>, vajino-rektal sÃ¼rÃ¼ntÃ¼<br>
                            7. IAP ile <strong>erken baÅŸlangÄ±Ã§lÄ±</strong> hastalÄ±k Ã¶nlenir, geÃ§ baÅŸlangÄ±Ã§lÄ± Ã¶nlenmez
                        </p>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>Test</th>
                            <th>GBS (S. agalactiae)</th>
                            <th>GAS (S. pyogenes)</th>
                        </tr>
                        <tr>
                            <td>Hemoliz</td>
                            <td>Î²</td>
                            <td>Î²</td>
                        </tr>
                        <tr>
                            <td>CAMP</td>
                            <td><b>POZÄ°TÄ°F</b></td>
                            <td>Negatif</td>
                        </tr>
                        <tr>
                            <td>HipÃ¼rat</td>
                            <td><b>POZÄ°TÄ°F</b></td>
                            <td>Negatif</td>
                        </tr>
                        <tr>
                            <td>Basitrasin</td>
                            <td><b>DÄ°RENÃ‡LÄ°</b></td>
                            <td>DuyarlÄ±</td>
                        </tr>
                        <tr>
                            <td>PYR</td>
                            <td>Negatif</td>
                            <td><b>POZÄ°TÄ°F</b></td>
                        </tr>
                        <tr>
                            <td>Lancefield</td>
                            <td>Grup B</td>
                            <td>Grup A</td>
                        </tr>
                    </table>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Soru tipi:</b> "YenidoÄŸanda sepsis + menenjit etkeni?" â†’ S. agalactiae (GBS)</li>
                        <li class="feature-item"><b>Soru tipi:</b> "CAMP testi pozitif streptokok?" â†’ S. agalactiae</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Gebelikte 36. hafta taramasÄ± hangi bakteri iÃ§in?" â†’ GBS</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Basitrasin direnÃ§li, Î²-hemolitik streptokok?" â†’ GBS</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Ä°ntrapartum profilaksi hangi etken iÃ§in?" â†’ GBS</li>
                        <li class="feature-item"><b>Soru tipi:</b> "HipÃ¼rat hidrolizi pozitif streptokok?" â†’ S. agalactiae</li>
                    </ul>
                `
            }
        ]
    },
    {
        id: 4,
        category: "bakteriyoloji",
        title: "Bakteriyoloji AyÄ±rÄ±cÄ± Testler",
        subtitle: "Biyokimyasal Testler ve Ã–nemli Etkenler",
        summary: "Klinik mikrobiyolojide bakterilerin identifikasyonunda kullanÄ±lan temel biyokimyasal ve fenotipik testlerin kapsamlÄ± Ã¶zeti. CAMP, katalaz, oksidaz, koagÃ¼laz ve diÄŸer kritik testler.",
        tags: ["Biyokimyasal Test", "Katalaz", "Oksidaz", "KoagÃ¼laz", "CAMP", "TanÄ±sal Mikrobiyoloji"],
        sections: [
            {
                title: "Hemoliz ve CAMP Testleri",
                icon: "fas fa-tint",
                content: `
                    <p>Hemoliz paterni, Ã¶zellikle <strong>Streptococcus</strong> ve <strong>Staphylococcus</strong> tÃ¼rlerinin ayÄ±rÄ±mÄ±nda kritik Ã¶neme sahiptir.</p>
                    
                    <div class="sub-section">
                        <h4 class="sub-section__title">Hemoliz Tipleri</h4>
                        <table class="article-table">
                            <tr>
                                <th>Hemoliz Tipi</th>
                                <th>GÃ¶rÃ¼nÃ¼m</th>
                                <th>Ã–nemli Etkenler</th>
                            </tr>
                            <tr>
                                <td><b>Î±-Hemoliz</b></td>
                                <td>YeÅŸilimsi zon (parsiyel)</td>
                                <td>S. pneumoniae, S. viridans grubu</td>
                            </tr>
                            <tr>
                                <td><b>Î²-Hemoliz</b></td>
                                <td>Berrak zon (tam)</td>
                                <td>S. pyogenes, S. agalactiae, S. aureus, L. monocytogenes</td>
                            </tr>
                            <tr>
                                <td><b>Î³-Hemoliz</b></td>
                                <td>Hemoliz yok</td>
                                <td>Enterococcus spp., S. saprophyticus</td>
                            </tr>
                        </table>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">CAMP Testi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Prensip:</b> S. aureus Î²-toksini ile sinerjistik hemoliz</li>
                            <li class="feature-item"><b>GÃ¶rÃ¼nÃ¼m:</b> Ok baÅŸÄ± ÅŸeklinde geniÅŸlemiÅŸ hemoliz</li>
                            <li class="feature-item"><b>CAMP POZÄ°TÄ°F:</b> <strong>S. agalactiae (GBS)</strong></li>
                            <li class="feature-item"><b>YanlÄ±ÅŸ pozitiflik:</b> BazÄ± Listeria tÃ¼rleri (L. ivanovii)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Ters (Reverse) CAMP Testi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Prensip:</b> S. agalactiae ile yapÄ±lÄ±r (CAMP faktÃ¶r kaynaÄŸÄ±)</li>
                            <li class="feature-item"><b>GÃ¶rÃ¼nÃ¼m:</b> KesiÅŸim noktasÄ±nda hemoliz <strong>Ä°NHÄ°BÄ°SYONU</strong> (bumerang ÅŸekli)</li>
                            <li class="feature-item"><b>Ters CAMP POZÄ°TÄ°F:</b> <strong>Clostridium perfringens</strong>, <strong>Arcanobacterium haemolyticum</strong></li>
                        </ul>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">SÄ±nav Ä°pucu</p>
                        <p class="highlight-box__content">
                            <strong>CAMP (+):</strong> GBS (ok ucu hemoliz)<br>
                            <strong>Ters CAMP (+):</strong> C. perfringens (hemoliz inhibisyonu)
                        </p>
                    </div>
                `
            },
            {
                title: "Katalaz ve Oksidaz Testleri",
                icon: "fas fa-flask",
                content: `
                    <p>Temel enzim testleri bakterilerin ilk ayrÄ±mÄ±nda kullanÄ±lÄ±r.</p>
                    
                    <div class="sub-section">
                        <h4 class="sub-section__title">Katalaz Testi</h4>
                        <p><strong>Prensip:</strong> Hâ‚‚Oâ‚‚ â†’ Hâ‚‚O + Oâ‚‚ (kabarcÄ±k oluÅŸumu)</p>
                        <table class="article-table">
                            <tr>
                                <th>Katalaz POZÄ°TÄ°F</th>
                                <th>Katalaz NEGATÄ°F</th>
                            </tr>
                            <tr>
                                <td>
                                    <b>Staphylococcus</b> tÃ¼m tÃ¼rleri<br>
                                    Enterobacteriaceae<br>
                                    Pseudomonas<br>
                                    Bacillus<br>
                                    Listeria<br>
                                    Corynebacterium<br>
                                    Mycobacterium<br>
                                    Neisseria<br>
                                    Haemophilus
                                </td>
                                <td>
                                    <b>Streptococcus</b> tÃ¼m tÃ¼rleri<br>
                                    <b>Enterococcus</b><br>
                                    Clostridium<br>
                                    Lactobacillus<br>
                                    Abiotrophia
                                </td>
                            </tr>
                        </table>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Klinik KullanÄ±m:</strong> Katalaz testi Gram (+) koklarÄ±n ilk ayrÄ±mÄ±nda kritiktir:<br>
                        <strong>Katalaz (+) Gram (+) kok = Staphylococcus</strong><br>
                        <strong>Katalaz (-) Gram (+) kok = Streptococcus/Enterococcus</strong></p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Oksidaz Testi</h4>
                        <p><strong>Prensip:</strong> Sitokrom c oksidaz varlÄ±ÄŸÄ±nÄ± tespit eder (mor/mavi renk)</p>
                        <table class="article-table">
                            <tr>
                                <th>Oksidaz POZÄ°TÄ°F</th>
                                <th>Oksidaz NEGATÄ°F</th>
                            </tr>
                            <tr>
                                <td>
                                    <b>Pseudomonas</b><br>
                                    <b>Neisseria</b><br>
                                    <b>Vibrio</b><br>
                                    <b>Campylobacter</b><br>
                                    <b>Helicobacter</b><br>
                                    Aeromonas<br>
                                    Plesiomonas<br>
                                    Alcaligenes<br>
                                    Moraxella<br>
                                    Pasteurella
                                </td>
                                <td>
                                    <b>Enterobacteriaceae</b> (tÃ¼mÃ¼!)<br>
                                    Staphylococcus<br>
                                    Streptococcus<br>
                                    Acinetobacter<br>
                                    Stenotrophomonas
                                </td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Kritik AyrÄ±m</p>
                        <p class="highlight-box__content">
                            <strong>Gram (-) basil, Oksidaz (+):</strong> Pseudomonas, Vibrio, Aeromonas dÃ¼ÅŸÃ¼n<br>
                            <strong>Gram (-) basil, Oksidaz (-):</strong> Enterobacteriaceae dÃ¼ÅŸÃ¼n<br>
                            <strong>Ä°stisna:</strong> Acinetobacter oksidaz (-) non-fermentatif!
                        </p>
                    </div>
                `
            },
            {
                title: "KoagÃ¼laz Testleri",
                icon: "fas fa-vial",
                content: `
                    <p>KoagÃ¼laz testi <strong>Staphylococcus aureus</strong>'u diÄŸer stafilokoklardan ayÄ±rmada altÄ±n standarttÄ±r.</p>
                    
                    <div class="sub-section">
                        <h4 class="sub-section__title">Serbest (TÃ¼p) KoagÃ¼laz</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Prensip:</b> Protrombini trombine Ã§evirir â†’ Fibrinojen pÄ±htÄ±laÅŸÄ±r</li>
                            <li class="feature-item"><b>SÃ¼re:</b> 4-24 saat inkÃ¼basyon</li>
                            <li class="feature-item"><b>AltÄ±n standart:</b> En gÃ¼venilir yÃ¶ntem</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">BaÄŸlÄ± (Lam/Slide) KoagÃ¼laz (Clumping Factor)</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>Prensip:</b> Fibrinojene doÄŸrudan baÄŸlanma â†’ AglÃ¼tinasyon</li>
                            <li class="feature-item"><b>SÃ¼re:</b> Saniyeler iÃ§inde sonuÃ§</li>
                            <li class="feature-item"><b>Avantaj:</b> HÄ±zlÄ± tarama</li>
                            <li class="feature-item"><b>Dezavantaj:</b> BazÄ± suÅŸlar negatif olabilir</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <tr>
                            <th>TÃ¼r</th>
                            <th>TÃ¼p KoagÃ¼laz</th>
                            <th>Lam KoagÃ¼laz</th>
                            <th>Klinik Ã–nemi</th>
                        </tr>
                        <tr>
                            <td><b>S. aureus</b></td>
                            <td><strong>POZÄ°TÄ°F</strong></td>
                            <td><strong>POZÄ°TÄ°F</strong></td>
                            <td>En Ã¶nemli patojen stafilokok</td>
                        </tr>
                        <tr>
                            <td><b>S. lugdunensis</b></td>
                            <td>Negatif</td>
                            <td><strong>POZÄ°TÄ°F</strong></td>
                            <td>S. aureus gibi virÃ¼lan KNS!</td>
                        </tr>
                        <tr>
                            <td><b>S. schleiferi</b></td>
                            <td>Negatif/Pozitif</td>
                            <td>DeÄŸiÅŸken</td>
                            <td>KÃ¶pek otit etkeni</td>
                        </tr>
                        <tr>
                            <td><b>S. intermedius</b></td>
                            <td><strong>POZÄ°TÄ°F</strong></td>
                            <td>DeÄŸiÅŸken</td>
                            <td>KÃ¶pek/kedi Ä±sÄ±rÄ±ÄŸÄ±</td>
                        </tr>
                        <tr>
                            <td><b>DiÄŸer KNS</b></td>
                            <td>Negatif</td>
                            <td>Negatif</td>
                            <td>S. epidermidis, S. saprophyticus vb.</td>
                        </tr>
                    </table>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>S. lugdunensis TuzaÄŸÄ±:</strong> Lam koagÃ¼laz POZÄ°TÄ°F olduÄŸu iÃ§in S. aureus ile karÄ±ÅŸabilir! Ancak tÃ¼p koagÃ¼laz NEGATÄ°F'tir. PYR testi ile ayrÄ±lÄ±r (S. lugdunensis PYR +, S. aureus PYR -).</p>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">KNS AyÄ±rÄ±mÄ±</p>
                        <p class="highlight-box__content">
                            <strong>Novobiosin DÄ°RENÃ‡LÄ°:</strong> S. saprophyticus (ÃœYE etkeni, genÃ§ kadÄ±nlarda)<br>
                            <strong>Novobiosin DUYARLI:</strong> S. epidermidis ve diÄŸer KNS
                        </p>
                    </div>
                `
            },
            {
                title: "Antibiyotik DuyarlÄ±lÄ±k ile AyÄ±rÄ±m",
                icon: "fas fa-pills",
                content: `
                    <p>BazÄ± bakterilerin identifikasyonunda spesifik antibiyotiklere duyarlÄ±lÄ±k/direnÃ§ kullanÄ±lÄ±r.</p>
                    
                    <table class="article-table">
                        <tr>
                            <th>Antibiyotik</th>
                            <th>DuyarlÄ±</th>
                            <th>DirenÃ§li</th>
                            <th>KullanÄ±m</th>
                        </tr>
                        <tr>
                            <td><b>Optokin (P disk)</b></td>
                            <td><strong>S. pneumoniae</strong></td>
                            <td>S. viridans grubu</td>
                            <td>Î±-hemolitik streptokoklarÄ±n ayrÄ±mÄ±</td>
                        </tr>
                        <tr>
                            <td><b>Basitrasin (A disk)</b></td>
                            <td><strong>S. pyogenes (GAS)</strong></td>
                            <td>S. agalactiae (GBS), diÄŸer Î²-hemolitik</td>
                            <td>Î²-hemolitik streptokoklarÄ±n ayrÄ±mÄ±</td>
                        </tr>
                        <tr>
                            <td><b>Novobiosin</b></td>
                            <td>S. epidermidis, diÄŸer KNS</td>
                            <td><strong>S. saprophyticus</strong></td>
                            <td>KNS ayrÄ±mÄ±</td>
                        </tr>
                        <tr>
                            <td><b>SXT (TMP-SMX)</b></td>
                            <td>S. agalactiae (GBS)</td>
                            <td><strong>S. pyogenes (GAS)</strong></td>
                            <td>GAS vs GBS ek test</td>
                        </tr>
                        <tr>
                            <td><b>Polimiksin B</b></td>
                            <td>Ã‡oÄŸu Gram (-)</td>
                            <td><strong>Proteus, Serratia, Burkholderia</strong></td>
                            <td>DoÄŸal direnÃ§ paterni</td>
                        </tr>
                        <tr>
                            <td><b>Vankomisisn</b></td>
                            <td>Ã‡oÄŸu Gram (+)</td>
                            <td><strong>Leuconostoc, Pediococcus, Lactobacillus</strong></td>
                            <td>DoÄŸal vanko-direnÃ§li Gram (+)</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">PnÃ¶mokok TanÄ±sÄ±</p>
                        <p class="highlight-box__content">
                            <strong>S. pneumoniae:</strong><br>
                            â€¢ Optokin DUYARLI (â‰¥14 mm)<br>
                            â€¢ Safrada ERÄ°R (deoksikolat testi +)<br>
                            â€¢ Î±-hemolitik<br>
                            â€¢ Lancefield grup antijeni YOK
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Streptococcus AyÄ±rÄ±cÄ± Testler Ã–zeti</h4>
                        <table class="article-table">
                            <tr>
                                <th>Test</th>
                                <th>S. pyogenes (GAS)</th>
                                <th>S. agalactiae (GBS)</th>
                                <th>S. pneumoniae</th>
                                <th>Enterococcus</th>
                            </tr>
                            <tr>
                                <td>Hemoliz</td>
                                <td>Î²</td>
                                <td>Î²</td>
                                <td>Î±</td>
                                <td>Î±, Î² veya Î³</td>
                            </tr>
                            <tr>
                                <td>Basitrasin</td>
                                <td><b>DuyarlÄ±</b></td>
                                <td>DirenÃ§li</td>
                                <td>-</td>
                                <td>DirenÃ§li</td>
                            </tr>
                            <tr>
                                <td>CAMP</td>
                                <td>Negatif</td>
                                <td><b>POZÄ°TÄ°F</b></td>
                                <td>-</td>
                                <td>Negatif</td>
                            </tr>
                            <tr>
                                <td>PYR</td>
                                <td><b>POZÄ°TÄ°F</b></td>
                                <td>Negatif</td>
                                <td>Negatif</td>
                                <td><b>POZÄ°TÄ°F</b></td>
                            </tr>
                            <tr>
                                <td>HipÃ¼rat</td>
                                <td>Negatif</td>
                                <td><b>POZÄ°TÄ°F</b></td>
                                <td>Negatif</td>
                                <td>DeÄŸiÅŸken</td>
                            </tr>
                            <tr>
                                <td>Optokin</td>
                                <td>-</td>
                                <td>-</td>
                                <td><b>DuyarlÄ±</b></td>
                                <td>DirenÃ§li</td>
                            </tr>
                            <tr>
                                <td>Safra Eskulin</td>
                                <td>Negatif</td>
                                <td>Negatif</td>
                                <td>Negatif</td>
                                <td><b>POZÄ°TÄ°F</b></td>
                            </tr>
                            <tr>
                                <td>%6.5 NaCl</td>
                                <td>Ãœremez</td>
                                <td>Ãœremez</td>
                                <td>Ãœremez</td>
                                <td><b>Ãœrer</b></td>
                            </tr>
                        </table>
                    </div>
                `
            },
            {
                title: "Ãœreaz ve Fenilalanin Testleri",
                icon: "fas fa-atom",
                content: `
                    <p>Enterobacteriaceae ve diÄŸer bakterilerin ayrÄ±mÄ±nda Ã¶nemli enzim testleridir.</p>
                    
                    <div class="sub-section">
                        <h4 class="sub-section__title">Ãœreaz Testi</h4>
                        <p><strong>Prensip:</strong> Ãœre â†’ NHâ‚ƒ + COâ‚‚ (pH artÄ±ÅŸÄ±, pembe renk)</p>
                        <table class="article-table">
                            <tr>
                                <th>Ãœreaz POZÄ°TÄ°F</th>
                                <th>HÄ±z</th>
                            </tr>
                            <tr>
                                <td><b>Proteus</b> tÃ¼rleri</td>
                                <td><strong>HIZLI</strong> (2-4 saat)</td>
                            </tr>
                            <tr>
                                <td><b>Helicobacter pylori</b></td>
                                <td><strong>HIZLI</strong> (ÃœRE-NEFES TESTÄ°!)</td>
                            </tr>
                            <tr>
                                <td><b>Brucella</b></td>
                                <td>YavaÅŸ</td>
                            </tr>
                            <tr>
                                <td><b>Klebsiella</b></td>
                                <td>YavaÅŸ</td>
                            </tr>
                            <tr>
                                <td><b>Cryptococcus neoformans</b></td>
                                <td>YavaÅŸ (maya!)</td>
                            </tr>
                            <tr>
                                <td>Morganella, Providencia</td>
                                <td>DeÄŸiÅŸken</td>
                            </tr>
                        </table>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Proteus Ã–zellikleri:</strong> HÄ±zlÄ± Ã¼reaz + Fenilalanin deaminaz + Swarming (kanlÄ± agarda yayÄ±lma) â†’ <strong>"PUF"</strong> (Proteus-Ãœreaz-Fenilalanin)</p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Fenilalanin Deaminaz Testi</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>POZÄ°TÄ°F:</b> Proteus, Morganella, Providencia (PMP grubu)</li>
                            <li class="feature-item"><b>NEGATÄ°F:</b> DiÄŸer Enterobacteriaceae</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Lizin/Ornitin Dekarboksilaz</h4>
                        <table class="article-table">
                            <tr>
                                <th>Bakteri</th>
                                <th>LDC</th>
                                <th>ODC</th>
                                <th>ADH</th>
                            </tr>
                            <tr>
                                <td>Salmonella</td>
                                <td><b>+</b></td>
                                <td><b>+</b></td>
                                <td>-</td>
                            </tr>
                            <tr>
                                <td>Shigella</td>
                                <td>-</td>
                                <td><b>+</b></td>
                                <td>-</td>
                            </tr>
                            <tr>
                                <td>Klebsiella</td>
                                <td><b>+</b></td>
                                <td>-</td>
                                <td>-</td>
                            </tr>
                            <tr>
                                <td>Enterobacter</td>
                                <td><b>+</b></td>
                                <td><b>+</b></td>
                                <td><b>+</b></td>
                            </tr>
                            <tr>
                                <td>Proteus mirabilis</td>
                                <td>-</td>
                                <td><b>+</b></td>
                                <td>-</td>
                            </tr>
                        </table>
                    </div>
                `
            },
            {
                title: "IMViC ve Enterik Testler",
                icon: "fas fa-bacteria",
                content: `
                    <p><strong>IMViC testleri</strong> Enterobacteriaceae iÃ§inde Ã¶zellikle E. coli ve Klebsiella ayrÄ±mÄ±nda kullanÄ±lÄ±r.</p>
                    
                    <div class="sub-section">
                        <h4 class="sub-section__title">IMViC Testleri</h4>
                        <table class="article-table">
                            <tr>
                                <th>Test</th>
                                <th>Prensip</th>
                                <th>E. coli</th>
                                <th>Klebsiella</th>
                                <th>Enterobacter</th>
                            </tr>
                            <tr>
                                <td><b>Ä°ndol (I)</b></td>
                                <td>Triptofan â†’ Ä°ndol</td>
                                <td><b>+</b></td>
                                <td>-</td>
                                <td>-</td>
                            </tr>
                            <tr>
                                <td><b>Metil KÄ±rmÄ±zÄ±sÄ± (M)</b></td>
                                <td>KarÄ±ÅŸÄ±k asit fermentasyonu</td>
                                <td><b>+</b></td>
                                <td>-</td>
                                <td>-</td>
                            </tr>
                            <tr>
                                <td><b>Voges-Proskauer (V)</b></td>
                                <td>Asetoin Ã¼retimi</td>
                                <td>-</td>
                                <td><b>+</b></td>
                                <td><b>+</b></td>
                            </tr>
                            <tr>
                                <td><b>Sitrat (C)</b></td>
                                <td>Tek C kaynaÄŸÄ± olarak kullanÄ±m</td>
                                <td>-</td>
                                <td><b>+</b></td>
                                <td><b>+</b></td>
                            </tr>
                        </table>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">IMViC Paterni</p>
                        <p class="highlight-box__content">
                            <strong>E. coli:</strong> + + - - (Ä°ndol +, MR +, VP -, Sitrat -)<br>
                            <strong>Klebsiella:</strong> - - + + (Ä°ndol -, MR -, VP +, Sitrat +)<br>
                            <strong>Enterobacter:</strong> - - + + (Klebsiella ile benzer)
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Ä°ndol Testi Pozitif Etkenler</h4>
                        <ul class="feature-list">
                            <li class="feature-item"><b>E. coli</b> (en sÄ±k)</li>
                            <li class="feature-item"><b>Proteus vulgaris</b> (P. mirabilis Ä°NDOL NEGATÄ°F!)</li>
                            <li class="feature-item"><b>Klebsiella oxytoca</b> (K. pneumoniae indol -)</li>
                            <li class="feature-item"><b>Vibrio cholerae</b></li>
                            <li class="feature-item"><b>Bacteroides fragilis</b></li>
                            <li class="feature-item"><b>Porphyromonas</b></li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">TSI (Triple Sugar Iron) Testi</h4>
                        <table class="article-table">
                            <tr>
                                <th>Patern</th>
                                <th>YÃ¼zey/Dip</th>
                                <th>Hâ‚‚S</th>
                                <th>Gaz</th>
                                <th>Ã–rnek Etken</th>
                            </tr>
                            <tr>
                                <td>A/A</td>
                                <td>Asit/Asit</td>
                                <td>-</td>
                                <td>+</td>
                                <td>E. coli, Klebsiella</td>
                            </tr>
                            <tr>
                                <td>K/A</td>
                                <td>Alkali/Asit</td>
                                <td><b>+</b></td>
                                <td>+</td>
                                <td><b>Salmonella</b></td>
                            </tr>
                            <tr>
                                <td>K/A</td>
                                <td>Alkali/Asit</td>
                                <td><b>+</b></td>
                                <td>+</td>
                                <td><b>Proteus</b> (swarming)</td>
                            </tr>
                            <tr>
                                <td>K/A</td>
                                <td>Alkali/Asit</td>
                                <td>-</td>
                                <td>-</td>
                                <td><b>Shigella</b></td>
                            </tr>
                            <tr>
                                <td>K/K</td>
                                <td>Alkali/Alkali</td>
                                <td>-</td>
                                <td>-</td>
                                <td>Pseudomonas (non-fermentatif)</td>
                            </tr>
                        </table>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Hâ‚‚S Pozitif Enterik Bakteriler:</strong> Salmonella, Proteus, Citrobacter, Edwardsiella â†’ <strong>"SPaCE"</strong></p>
                    </div>
                `
            },
            {
                title: "Ã–zel TanÄ±mlayÄ±cÄ± Testler",
                icon: "fas fa-microscope",
                content: `
                    <p>Belirli bakterilerin kesin tanÄ±sÄ±nda kullanÄ±lan spesifik testler.</p>
                    
                    <table class="article-table">
                        <tr>
                            <th>Test</th>
                            <th>Pozitif Etken(ler)</th>
                            <th>Klinik Ã–nemi</th>
                        </tr>
                        <tr>
                            <td><b>PYR (Pirrolidonil Arylamidaz)</b></td>
                            <td>S. pyogenes (GAS), Enterococcus, S. lugdunensis</td>
                            <td>GAS ve Enterococcus ayÄ±rÄ±mÄ±</td>
                        </tr>
                        <tr>
                            <td><b>Safra EskÃ¼lin</b></td>
                            <td>Enterococcus, Strep. bovis grubu</td>
                            <td>Enterococcus tanÄ±sÄ±</td>
                        </tr>
                        <tr>
                            <td><b>%6.5 NaCl ToleransÄ±</b></td>
                            <td>Enterococcus, bazÄ± Aerococcus</td>
                            <td>Strep'den ayrÄ±m</td>
                        </tr>
                        <tr>
                            <td><b>Safrada Erime</b></td>
                            <td>S. pneumoniae</td>
                            <td>Viridans'tan ayrÄ±m</td>
                        </tr>
                        <tr>
                            <td><b>X ve V FaktÃ¶r Gereksinimi</b></td>
                            <td>H. influenzae (X+V), H. parainfluenzae (sadece V)</td>
                            <td>Haemophilus tÃ¼rlerinin ayrÄ±mÄ±</td>
                        </tr>
                        <tr>
                            <td><b>Satellit Fenomeni</b></td>
                            <td>Haemophilus, Abiotrophia</td>
                            <td>NAD baÄŸÄ±mlÄ±lÄ±ÄŸÄ±</td>
                        </tr>
                        <tr>
                            <td><b>Nagler Reaksiyonu</b></td>
                            <td>C. perfringens (Î±-toksin = lesitinaz)</td>
                            <td>Gaz gangreni etkeni</td>
                        </tr>
                        <tr>
                            <td><b>Ã‡ift Zonlu Hemoliz</b></td>
                            <td>C. perfringens</td>
                            <td>Î¸ ve Î± toksinler</td>
                        </tr>
                        <tr>
                            <td><b>Åemsiye (Umbrella) Motilite</b></td>
                            <td>Listeria monocytogenes</td>
                            <td>25Â°C'de hareketli, 37Â°C'de hareketsiz</td>
                        </tr>
                        <tr>
                            <td><b>SoÄŸukta ZenginleÅŸtirme</b></td>
                            <td>Listeria, Yersinia</td>
                            <td>4Â°C'de Ã¼reme</td>
                        </tr>
                        <tr>
                            <td><b>String Test</b></td>
                            <td>Vibrio cholerae</td>
                            <td>%0.5 deoksikolatta mukoid iplik</td>
                        </tr>
                        <tr>
                            <td><b>Hippurate Hidrolizi</b></td>
                            <td>GBS, C. jejuni</td>
                            <td>Campylobacter tÃ¼rlerinin ayrÄ±mÄ±</td>
                        </tr>
                    </table>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Listeria Ã–zellikleri</p>
                        <p class="highlight-box__content">
                            <strong>Listeria monocytogenes:</strong><br>
                            â€¢ Gram (+) kÄ±sa basil, kokoid gÃ¶rÃ¼nebilir<br>
                            â€¢ Î²-hemolitik (dar zon)<br>
                            â€¢ Katalaz (+), Oksidaz (-)<br>
                            â€¢ 25Â°C'de <b>hareketli</b> (tumbling), 37Â°C'de hareketsiz<br>
                            â€¢ SoÄŸukta (4Â°C) Ã¼rer<br>
                            â€¢ EskÃ¼lin hidrolizi (+)
                        </p>
                    </div>
                `
            },
            {
                title: "Non-Fermentatif Gram (-) Basiller",
                icon: "fas fa-lungs-virus",
                content: `
                    <p>Glikoz fermente edemeyen, aerobik Gram (-) basillerin ayÄ±rÄ±mÄ±.</p>
                    
                    <table class="article-table">
                        <tr>
                            <th>Ã–zellik</th>
                            <th>P. aeruginosa</th>
                            <th>Acinetobacter</th>
                            <th>S. maltophilia</th>
                            <th>B. cepacia</th>
                        </tr>
                        <tr>
                            <td>Oksidaz</td>
                            <td><b>POZÄ°TÄ°F</b></td>
                            <td><b>NEGATÄ°F</b></td>
                            <td><b>NEGATÄ°F</b></td>
                            <td>POZÄ°TÄ°F</td>
                        </tr>
                        <tr>
                            <td>Hareket</td>
                            <td>Hareketli</td>
                            <td>Hareketsiz</td>
                            <td>Hareketli</td>
                            <td>Hareketli</td>
                        </tr>
                        <tr>
                            <td>Pigment</td>
                            <td>Piyosiyanin (mavi-yeÅŸil)</td>
                            <td>Yok</td>
                            <td>Yok</td>
                            <td>SarÄ±</td>
                        </tr>
                        <tr>
                            <td>Koku</td>
                            <td>ÃœzÃ¼m/mÄ±sÄ±r</td>
                            <td>Yok</td>
                            <td>Amonyak</td>
                            <td>Yok</td>
                        </tr>
                        <tr>
                            <td>Ã–nemli DirenÃ§</td>
                            <td>Ã‡oklu ilaÃ§</td>
                            <td>Karbapenem</td>
                            <td>Karbapenem (doÄŸal)</td>
                            <td>Aminoglikozid</td>
                        </tr>
                    </table>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>P. aeruginosa Pigmentleri:</strong><br>
                            â€¢ <b>Piyosiyanin:</b> Mavi-yeÅŸil (en karakteristik)<br>
                            â€¢ <b>Piyoverdin (Floresein):</b> SarÄ±-yeÅŸil, floresan<br>
                            â€¢ <b>Piyorubin:</b> KÄ±rmÄ±zÄ±-kahverengi<br>
                            â€¢ <b>Piyomelanin:</b> Kahverengi-siyah</p>
                    </div>

                    <div class="highlight-box">
                        <p class="highlight-box__title">Oksidaz (-) Non-Fermentatif</p>
                        <p class="highlight-box__content">
                            <strong>Acinetobacter:</strong> Kokobasil, hareketsiz<br>
                            <strong>Stenotrophomonas:</strong> TMP-SMX ile tedavi (karbapenem direnÃ§li!)
                        </p>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Ã–zet TablolarÄ±",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">HÄ±zlÄ± AyÄ±rÄ±cÄ± Test AlgoritmasÄ±</p>
                        <p class="highlight-box__content">
                            <strong>Gram (+) Kok:</strong><br>
                            â†’ Katalaz (+) = Staphylococcus â†’ KoagÃ¼laz (+) = S. aureus<br>
                            â†’ Katalaz (-) = Streptococcus/Enterococcus<br><br>
                            <strong>Gram (-) Basil:</strong><br>
                            â†’ Oksidaz (+) = Non-Enterobacteriaceae (Pseudomonas, Vibrio)<br>
                            â†’ Oksidaz (-) = Enterobacteriaceae
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">En SÄ±k Sorulan Test-Bakteri EÅŸleÅŸmeleri</h4>
                        <table class="article-table">
                            <tr>
                                <th>Test/Ã–zellik</th>
                                <th>Pozitif Etken</th>
                                <th>SÄ±nav Ä°pucu</th>
                            </tr>
                            <tr>
                                <td>CAMP (+)</td>
                                <td>S. agalactiae</td>
                                <td>Ok ucu hemoliz</td>
                            </tr>
                            <tr>
                                <td>Ters CAMP (+)</td>
                                <td>C. perfringens</td>
                                <td>Hemoliz inhibisyonu</td>
                            </tr>
                            <tr>
                                <td>Optokin duyarlÄ±</td>
                                <td>S. pneumoniae</td>
                                <td>Î±-hemolitik</td>
                            </tr>
                            <tr>
                                <td>Basitrasin duyarlÄ±</td>
                                <td>S. pyogenes</td>
                                <td>Î²-hemolitik GAS</td>
                            </tr>
                            <tr>
                                <td>Novobiosin direnÃ§li</td>
                                <td>S. saprophyticus</td>
                                <td>GenÃ§ kadÄ±n ÃœYE</td>
                            </tr>
                            <tr>
                                <td>Lam koagÃ¼laz (+), TÃ¼p (-)</td>
                                <td>S. lugdunensis</td>
                                <td>VirÃ¼lan KNS</td>
                            </tr>
                            <tr>
                                <td>HÄ±zlÄ± Ã¼reaz (+)</td>
                                <td>Proteus, H. pylori</td>
                                <td>Ãœre nefes testi</td>
                            </tr>
                            <tr>
                                <td>Hâ‚‚S (+)</td>
                                <td>Salmonella, Proteus</td>
                                <td>TSI'da siyahlaÅŸma</td>
                            </tr>
                            <tr>
                                <td>Ä°ndol (+)</td>
                                <td>E. coli, P. vulgaris</td>
                                <td>P. mirabilis indol (-)</td>
                            </tr>
                            <tr>
                                <td>VP (+)</td>
                                <td>Klebsiella, Enterobacter</td>
                                <td>E. coli VP (-)</td>
                            </tr>
                            <tr>
                                <td>Åemsiye motilite</td>
                                <td>Listeria</td>
                                <td>25Â°C'de hareketli</td>
                            </tr>
                            <tr>
                                <td>Oksidaz (+) Gram (-)</td>
                                <td>Pseudomonas, Vibrio</td>
                                <td>Non-Enterobacteriaceae</td>
                            </tr>
                            <tr>
                                <td>Safra eskÃ¼lin (+)</td>
                                <td>Enterococcus</td>
                                <td>%40 safrada Ã¼reme</td>
                            </tr>
                        </table>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">HafÄ±za KodlarÄ±</p>
                        <p class="mnemonic-box__text">
                            <b>Hâ‚‚S (+):</b> "SPaCE" â†’ Salmonella, Proteus, Citrobacter, Edwardsiella<br>
                            <b>Ãœreaz (+):</b> "PUNCH-K" â†’ Proteus, Ureaplasma, Nocardia, Cryptococcus, H. pylori, Klebsiella<br>
                            <b>PYR (+):</b> GAS + Enterococcus + S. lugdunensis
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li class="feature-item"><b>Soru tipi:</b> "Katalaz (+), KoagÃ¼laz (+) Gram (+) kok?" â†’ S. aureus</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Optokin duyarlÄ±, safrada eriyen Î±-hemolitik?" â†’ S. pneumoniae</li>
                        <li class="feature-item"><b>Soru tipi:</b> "CAMP testi ok ucu hemoliz?" â†’ S. agalactiae</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Oksidaz (+), mavi-yeÅŸil pigment?" â†’ P. aeruginosa</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Ä°ndol (+), laktoz (+), TSI A/A?" â†’ E. coli</li>
                        <li class="feature-item"><b>Soru tipi:</b> "Novobiosin direnÃ§li KNS?" â†’ S. saprophyticus</li>
                    </ul>
                `
            }
        ]
    },
    {
        id: 5,
        title: "MolekÃ¼ler TanÄ± YÃ¶ntemleri",
        subtitle: "PCR, RT-PCR, qPCR, NGS ve UygulamalarÄ±",
        category: "laboratuvar",
        icon: "fa-dna",
        color: "#3b82f6",
        lastUpdated: "2024-01-10",
        readTime: "30 dk",
        summary: "MolekÃ¼ler biyoloji tekniklerinin tanÄ± amaÃ§lÄ± kullanÄ±mÄ±. PCR, RT-PCR, qPCR, NGS yÃ¶ntemlerinin prensipleri, uygulamalarÄ± ve yorumlanmasÄ±.",
        tags: ["PCR", "MolekÃ¼ler TanÄ±", "RT-PCR", "qPCR", "NGS", "DNA Amplifikasyonu"],
        sections: [
            {
                title: "PCR (Polimeraz Zincir Reaksiyonu)",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-atom"></i> Temel Prensipler</h4>
                        <ul class="feature-list">
                            <li><strong>DNA Amplifikasyonu:</strong> Spesifik DNA bÃ¶lgelerinin Ã§oÄŸaltÄ±lmasÄ±</li>
                            <li><strong>BaÅŸlangÄ±Ã§ Malzemeleri:</strong> DNA ÅŸablonu, primerler, dNTP'ler, Taq polimeraz</li>
                            <li><strong>Basamaklar:</strong> DenatÃ¼rasyon, Annealing, Uzatma</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">PCR SÃ¼reci</h4>
                        <ol class="feature-list">
                            <li><b>DenatÃ¼rasyon:</b> DNA'nÄ±n 94-98Â°C'de ayrÄ±lmasÄ±</li>
                            <li><b>Annealing:</b> Primerlerin 50-65Â°C'de DNA'ya baÄŸlanmasÄ±</li>
                            <li><b>Uzatma:</b> Taq polimeraz ile yeni DNA ipliklerinin sentezi (72Â°C)</li>
                            <li><b>Tekrarlama:</b> 25-35 dÃ¶ngÃ¼ boyunca yukarÄ±daki adÄ±mlarÄ±n tekrarÄ±</li>
                        </ol>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <div class="alert-box__icon"><i class="fas fa-exclamation-triangle"></i></div>
                        <div class="alert-box__content">
                            <strong>Kontaminasyon Riski:</strong> PCR, kontaminasyona karÅŸÄ± hassastÄ±r. Negatif kontrollerle doÄŸrulama yapÄ±lmalÄ±dÄ±r.
                        </div>
                    </div>
                `
            },
            {
                title: "RT-PCR (Revers Transkriptaz PCR)",
                content: `
                    <div class="highlight-box highlight-box--secondary">
                        <h4><i class="fas fa-rna"></i> Temel Prensipler</h4>
                        <ul class="feature-list">
                            <li><strong>RNA Amplifikasyonu:</strong> Spesifik RNA bÃ¶lgelerinin Ã§oÄŸaltÄ±lmasÄ±</li>
                            <li><strong>BaÅŸlangÄ±Ã§ Malzemeleri:</strong> RNA ÅŸablonu, primerler, dNTP'ler, Taq polimeraz, revers transkriptaz</li>
                            <li><strong>Basamaklar:</strong> DenatÃ¼rasyon, Annealing, Uzatma</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">RT-PCR SÃ¼reci</h4>
                        <ol class="feature-list">
                            <li><b>RNA'nÄ±n Ekstraksiyonu:</b> HÃ¼crelerden RNA'nÄ±n izole edilmesi</li>
                            <li><b>Revers Transkripsiyon:</b> RNA'nÄ±n cDNA'ya dÃ¶nÃ¼ÅŸtÃ¼rÃ¼lmesi</li>
                            <li><b>PCR Amplifikasyonu:</b> cDNA'nÄ±n Ã§oÄŸaltÄ±lmasÄ±</li>
                            <li><b>TeÅŸhis:</b> AmpliconlarÄ±n elektroforez ile analizi</li>
                        </ol>
                    </div>

                    <div class="alert-box alert-box--info">
                        <div class="alert-box__icon"><i class="fas fa-lightbulb"></i></div>
                        <div class="alert-box__content">
                            <strong>COVID-19 TanÄ±sÄ±nda KullanÄ±mÄ±:</strong><br>
                            â€¢ Viral RNA'nÄ±n hÄ±zlÄ± ve spesifik tespiti iÃ§in kullanÄ±lÄ±r<br>
                            â€¢ AltÄ±n standart yÃ¶ntemdir
                        </div>
                    </div>
                `
            },
            {
                title: "qPCR (Kantitatif PCR)",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-calculator"></i> Temel Prensipler</h4>
                        <ul class="feature-list">
                            <li><strong>DNA Miktar Belirleme:</strong> PCR ile amplifiye edilen DNA'nÄ±n miktarÄ±nÄ±n belirlenmesi</li>
                            <li><strong>BaÅŸlangÄ±Ã§ Malzemeleri:</strong> DNA ÅŸablonu, primerler, dNTP'ler, Taq polimeraz, floresan boyalar</li>
                            <li><strong>Basamaklar:</strong> DenatÃ¼rasyon, Annealing, Uzatma</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">qPCR SÃ¼reci</h4>
                        <ol class="feature-list">
                            <li><b>DenatÃ¼rasyon:</b> DNA'nÄ±n 94-98Â°C'de ayrÄ±lmasÄ±</li>
                            <li><b>Annealing:</b> Primerlerin 50-65Â°C'de DNA'ya baÄŸlanmasÄ±</li>
                            <li><b>Uzatma:</b> Taq polimeraz ile yeni DNA ipliklerinin sentezi (72Â°C)</li>
                            <li><b>Floresan Sinyali:</b> Her dÃ¶ngÃ¼de floresan sinyalinin Ã¶lÃ§Ã¼lmesi</li>
                            <li><b>TeÅŸhis:</b> Sinyal yoÄŸunluÄŸuna gÃ¶re baÅŸlangÄ±Ã§ DNA miktarÄ±nÄ±n hesaplanmasÄ±</li>
                        </ol>
                    </div>

                    <div class="alert-box alert-box--info">
                        <div class="alert-box__icon"><i class="fas fa-lightbulb"></i></div>
                        <div class="alert-box__content">
                            <strong>GerÃ§ek ZamanlÄ± Ä°zleme:</strong><br>
                            â€¢ qPCR, amplifikasyonun her dÃ¶ngÃ¼sÃ¼nde floresan sinyalÄ±nÄ± Ã¶lÃ§erek gerÃ§ek zamanlÄ± veri saÄŸlar<br>
                            â€¢ SonuÃ§lar genellikle dÃ¶ngÃ¼ eÅŸiÄŸi (Ct) deÄŸeri ile raporlanÄ±r
                        </div>
                    </div>
                `
            },
            {
                title: "NGS (Next Generation Sequencing)",
                content: `
                    <div class="highlight-box highlight-box--secondary">
                        <h4><i class="fas fa-sequence"></i> Temel Prensipler</h4>
                        <ul class="feature-list">
                            <li><strong>Paralel Okuma:</strong> Milyonlarca DNA parÃ§asÄ±nÄ±n aynÄ± anda dizilmesi</li>
                            <li><strong>BaÅŸlangÄ±Ã§ Malzemeleri:</strong> DNA ÅŸablonu, dizileme adaptÃ¶rleri, biyoinformatik analiz yazÄ±lÄ±mlarÄ±</li>
                            <li><strong>Basamaklar:</strong> KÃ¼tÃ¼phane hazÄ±rlÄ±ÄŸÄ±, dizileme, veri analizi</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">NGS SÃ¼reci</h4>
                        <ol class="feature-list">
                            <li><b>KÃ¼tÃ¼phane HazÄ±rlÄ±ÄŸÄ±:</b> DNA'nÄ±n parÃ§alanmasÄ± ve dizileme adaptÃ¶rleri ile birleÅŸtirilmesi</li>
                            <li><b>Dizileme:</b> Paralel olarak milyonlarca DNA parÃ§asÄ±nÄ±n dizilmesi</li>
                            <li><b>Veri Analizi:</b> Dizilen verilerin biyoinformatik araÃ§larla analizi</li>
                            <li><b>Raporlama:</b> SonuÃ§larÄ±n yorumlanmasÄ± ve raporlanmasÄ±</li>
                        </ol>
                    </div>

                    <div class="alert-box alert-box--info">
                        <div class="alert-box__icon"><i class="fas fa-lightbulb"></i></div>
                        <div class="alert-box__content">
                            <strong>Uygulama AlanlarÄ±:</strong><br>
                            â€¢ Genom dizilimi, hedefe yÃ¶nelik dizilimi, RNA dizilimi<br>
                            â€¢ Kanser genetiÄŸi, mikrobiyom analizi, bulaÅŸÄ±cÄ± hastalÄ±klarÄ±n tanÄ±sÄ±
                        </div>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Noktalar",
                content: `
                    <div class="highlight-box">
                        <p class="highlight-box__title">TUS/Yeterlilik Klasikleri</p>
                        <p class="highlight-box__content">
                            1. <strong>PCR:</strong> DNA amplifikasyonu, kontaminasyona dikkat!<br>
                            2. <strong>RT-PCR:</strong> RNA'dan cDNA'ya, viral yÃ¼k tayini<br>
                            3. <strong>qPCR:</strong> Kantitatif, gerÃ§ek zamanlÄ± PCR<br>
                            4. <strong>NGS:</strong> Paralel dizileme, biyoinformatik analizi ÅŸart
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <div class="alert-box__icon"><i class="fas fa-brain"></i></div>
                        <div class="alert-box__content">
                            <strong>HafÄ±za KodlarÄ±:</strong><br><br>
                            â€¢ <strong>"PCR = DNA, RT-PCR = RNA"</strong><br>
                            â€¢ <strong>"qPCR = Kantitatif, NGS = Paralel dizileme"</strong><br>
                            â€¢ <strong>"COVID-19 = RT-PCR ile tanÄ±"</strong><br>
                            â€¢ <strong>"HIV = 4. nesil test ile tarama, RNA ile doÄŸrulama"</strong>
                        </div>
                    </div>
                `
            }
        ]
    },
    {
        id: 6,
        title: "Serolojik TanÄ± AlgoritmalarÄ±",
        subtitle: "Hepatitler, HIV, Sifiliz, TORCH ve Klinik DoÄŸrulama Testleri",
        category: "laboratuvar",
        icon: "fa-vials",
        color: "#8b5cf6",
        lastUpdated: "2024-01-15",
        readTime: "25 dk",
        summary: "Klinik mikrobiyolojide serolojik tanÄ± algoritmalarÄ±nÄ±n kapsamlÄ± Ã¶zeti. Hepatit B/C serolojisi, HIV tanÄ± algoritmasÄ±, sifiliz tarama ve doÄŸrulama, TORCH paneli yorumlarÄ±.",
        tags: ["Hepatit B", "Hepatit C", "HIV", "Sifiliz", "TORCH", "Seroloji", "TanÄ± AlgoritmasÄ±"],
        sections: [
            {
                title: "Hepatit B Serolojisi",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-star"></i> Temel BelirteÃ§ler</h4>
                        <ul class="feature-list">
                            <li><strong>HBsAg:</strong> Aktif enfeksiyon gÃ¶stergesi (yÃ¼zey antijeni)</li>
                            <li><strong>Anti-HBs:</strong> BaÄŸÄ±ÅŸÄ±klÄ±k gÃ¶stergesi (â‰¥10 mIU/mL koruyucu)</li>
                            <li><strong>Anti-HBc IgM:</strong> Akut enfeksiyon / alevlenme</li>
                            <li><strong>Anti-HBc IgG:</strong> GeÃ§irilmiÅŸ enfeksiyon (Ã¶mÃ¼r boyu pozitif kalÄ±r)</li>
                            <li><strong>HBeAg:</strong> Aktif viral replikasyon, yÃ¼ksek bulaÅŸtÄ±rÄ±cÄ±lÄ±k</li>
                            <li><strong>Anti-HBe:</strong> Replikasyonun azalmasÄ±, serokonversiyon</li>
                            <li><strong>HBV DNA:</strong> Viral yÃ¼k, tedavi takibi</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Hepatit B TanÄ± AlgoritmasÄ±</h4>
                        <ol class="feature-list">
                            <li><b>HBsAg:</b> Aktif enfeksiyon gÃ¶stergesi</li>
                            <li><b>Anti-HBs:</b> BaÄŸÄ±ÅŸÄ±klÄ±k durumu (aÅŸÄ± veya iyileÅŸme sonrasÄ±)</li>
                            <li><b>Anti-HBc:</b> GeÃ§irilmiÅŸ enfeksiyon veya aÅŸÄ± yanÄ±tÄ±</li>
                            <li><b>HBeAg ve Anti-HBe:</b> Viral replikasyon durumu</li>
                            <li><b>HBV DNA:</b> Aktif viral yÃ¼k tayini</li>
                        </ol>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <div class="alert-box__icon"><i class="fas fa-exclamation-triangle"></i></div>
                        <div class="alert-box__content">
                            <strong>Pencere DÃ¶nemi:</strong> HBsAg kaybolmuÅŸ, Anti-HBs henÃ¼z oluÅŸmamÄ±ÅŸ dÃ¶nem. Bu dÃ¶nemde <strong>sadece Anti-HBc IgM pozitif</strong> bulunur! Kan bankasÄ± iÃ§in kritik Ã¶neme sahiptir.
                        </div>
                    </div>

                    <div class="alert-box alert-box--info">
                        <div class="alert-box__icon"><i class="fas fa-lightbulb"></i></div>
                        <div class="alert-box__content">
                            <strong>AÅŸÄ±lÄ± vs Ä°yileÅŸmiÅŸ AyÄ±rÄ±mÄ±:</strong><br>
                            â€¢ <strong>AÅŸÄ±lÄ±:</strong> Sadece Anti-HBs (+) - HBsAg aÅŸÄ±sÄ± sadece yÃ¼zey antijenini iÃ§erir<br>
                            â€¢ <strong>Ä°yileÅŸmiÅŸ:</strong> Anti-HBs (+) VE Anti-HBc IgG (+) - DoÄŸal enfeksiyon tÃ¼m antijenlere maruziyete neden olur
                        </div>
                    </div>
                `
            },
            {
                title: "Hepatit C ve Delta Hepatiti",
                content: `
                    <h4><i class="fas fa-procedures"></i> Hepatit C TanÄ± AlgoritmasÄ±</h4>
                    <div class="highlight-box highlight-box--secondary">
                        <ol class="feature-list">
                            <li><strong>Tarama:</strong> Anti-HCV (EIA/ELISA)</li>
                            <li><strong>DoÄŸrulama:</strong> HCV RNA (PCR) - altÄ±n standart</li>
                            <li><strong>Genotipleme:</strong> Tedavi planlamasÄ± iÃ§in (6 majÃ¶r genotip)</li>
                        </ol>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Anti-HCV</th>
                                <th>HCV RNA</th>
                                <th>Yorum</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Negatif</td>
                                <td>Negatif</td>
                                <td>Enfeksiyon yok</td>
                            </tr>
                            <tr>
                                <td><strong>Pozitif</strong></td>
                                <td><strong>Pozitif</strong></td>
                                <td><strong>Aktif HCV enfeksiyonu</strong></td>
                            </tr>
                            <tr>
                                <td>Pozitif</td>
                                <td>Negatif</td>
                                <td>GeÃ§irilmiÅŸ/iyileÅŸmiÅŸ VEYA yalancÄ± (+)</td>
                            </tr>
                            <tr>
                                <td>Negatif</td>
                                <td>Pozitif</td>
                                <td>Erken akut enfeksiyon (serokonversiyon Ã¶ncesi)</td>
                            </tr>
                        </tbody>
                    </table>

                    <h4><i class="fas fa-project-diagram"></i> Hepatit Delta (HDV)</h4>
                    <div class="alert-box alert-box--danger">
                        <div class="alert-box__icon"><i class="fas fa-exclamation-circle"></i></div>
                        <div class="alert-box__content">
                            <strong>HDV = Defektif virÃ¼s:</strong> Replikasyon iÃ§in HBV'nin HBsAg'sine ihtiyaÃ§ duyar. HBsAg (-) kiÅŸide HDV enfeksiyonu OLMAZ!
                        </div>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Durum</th>
                                <th>TanÄ±m</th>
                                <th>Anti-HBc IgM</th>
                                <th>Prognoz</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Koinfeksiyon</strong></td>
                                <td>HBV + HDV aynÄ± anda</td>
                                <td><strong>Pozitif</strong></td>
                                <td>Genellikle iyileÅŸir (%90)</td>
                            </tr>
                            <tr>
                                <td><strong>SÃ¼perinfeksiyon</strong></td>
                                <td>Kronik HBV + HDV eklenmesi</td>
                                <td><strong>Negatif</strong></td>
                                <td>KÃ¶tÃ¼ prognoz, hÄ±zlÄ± siroz</td>
                            </tr>
                        </tbody>
                    </table>
                `
            },
            {
                title: "HIV TanÄ± AlgoritmasÄ±",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-microscope"></i> HIV Test YÃ¶ntemleri</h4>
                        <ul class="feature-list">
                            <li><strong>4. Nesil Combo Test:</strong> HIV-1/2 antikoru + p24 antijeni (tarama testi)</li>
                            <li><strong>HIV-1/HIV-2 Antikor AyÄ±rÄ±mÄ±:</strong> Tip tayini iÃ§in</li>
                            <li><strong>HIV RNA (NAT):</strong> Viral yÃ¼k, erken tanÄ±, tedavi takibi</li>
                            <li><strong>Western Blot:</strong> ArtÄ±k rutin doÄŸrulamada kullanÄ±lmÄ±yor (CDC 2014)</li>
                        </ul>
                    </div>

                    <h4><i class="fas fa-project-diagram"></i> CDC Ã–nerisi: 3 BasamaklÄ± Algoritma</h4>
                    <div class="highlight-box highlight-box--secondary">
                        <ol class="feature-list">
                            <li><strong>1. Basamak:</strong> 4. nesil Ag/Ab combo test</li>
                            <li><strong>2. Basamak:</strong> Pozitifse â†’ HIV-1/HIV-2 antikor ayÄ±rÄ±m testi</li>
                            <li><strong>3. Basamak:</strong> Belirsizse â†’ HIV-1 RNA (NAT)</li>
                        </ol>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>4. Nesil Test</th>
                                <th>HIV-1/2 Ab AyÄ±rÄ±m</th>
                                <th>HIV-1 RNA</th>
                                <th>Yorum</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Negatif</td>
                                <td>-</td>
                                <td>-</td>
                                <td>HIV negatif</td>
                            </tr>
                            <tr>
                                <td>Pozitif</td>
                                <td>HIV-1 (+)</td>
                                <td>-</td>
                                <td><strong>HIV-1 enfeksiyonu</strong></td>
                            </tr>
                            <tr>
                                <td>Pozitif</td>
                                <td>HIV-2 (+)</td>
                                <td>-</td>
                                <td><strong>HIV-2 enfeksiyonu</strong></td>
                            </tr>
                            <tr>
                                <td>Pozitif</td>
                                <td>Belirsiz</td>
                                <td><strong>Pozitif</strong></td>
                                <td><strong>Akut HIV-1</strong> (serokonversiyon Ã¶ncesi)</td>
                            </tr>
                            <tr>
                                <td>Pozitif</td>
                                <td>Belirsiz</td>
                                <td>Negatif</td>
                                <td>YalancÄ± pozitif, takip</td>
                            </tr>
                        </tbody>
                    </table>

                    <div class="alert-box alert-box--warning">
                        <div class="alert-box__icon"><i class="fas fa-clock"></i></div>
                        <div class="alert-box__content">
                            <strong>Pencere DÃ¶nemi SÃ¼releri:</strong><br>
                            â€¢ <strong>4. nesil test:</strong> ~18 gÃ¼n (p24 antijeni sayesinde kÄ±saldÄ±)<br>
                            â€¢ <strong>3. nesil test:</strong> ~22 gÃ¼n (sadece antikor)<br>
                            â€¢ <strong>HIV RNA:</strong> ~10-12 gÃ¼n (en erken pozitifleÅŸen)
                        </div>
                    </div>
                `
            },
            {
                title: "Sifiliz TanÄ± AlgoritmasÄ±",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-vial"></i> Test Kategorileri</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>Non-Treponemal (NTT)</th>
                                    <th>Treponemal (TT)</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>RPR, VDRL</td>
                                    <td>TPHA, TPPA, FTA-ABS, EIA/CIA</td>
                                </tr>
                                <tr>
                                    <td>HastalÄ±k aktivitesi gÃ¶sterir</td>
                                    <td>Maruziyeti gÃ¶sterir (Ã¶mÃ¼r boyu +)</td>
                                </tr>
                                <tr>
                                    <td>Tedavi ile titre dÃ¼ÅŸer</td>
                                    <td>Tedavi ile deÄŸiÅŸmez</td>
                                </tr>
                                <tr>
                                    <td>YalancÄ± (+) sÄ±k</td>
                                    <td>Daha spesifik</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <h4><i class="fas fa-exchange-alt"></i> Geleneksel vs Ters Algoritma</h4>
                    <div class="highlight-box highlight-box--secondary">
                        <h5>Geleneksel Algoritma:</h5>
                        <p><strong>NTT (RPR/VDRL)</strong> â†’ Pozitifse â†’ <strong>TT (TPHA)</strong> ile doÄŸrula</p>
                        
                        <h5>Ters (Reverse) Algoritma:</h5>
                        <p><strong>TT (EIA/CIA)</strong> â†’ Pozitifse â†’ <strong>NTT (RPR)</strong> ile aktivite deÄŸerlendir</p>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>TT (EIA)</th>
                                <th>NTT (RPR)</th>
                                <th>TPPA</th>
                                <th>Yorum</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Pozitif</td>
                                <td>Pozitif</td>
                                <td>-</td>
                                <td><strong>Aktif sifiliz</strong> - tedavi gerekli</td>
                            </tr>
                            <tr>
                                <td>Pozitif</td>
                                <td>Negatif</td>
                                <td>Pozitif</td>
                                <td>GeÃ§irilmiÅŸ tedavi edilmiÅŸ sifiliz</td>
                            </tr>
                            <tr>
                                <td>Pozitif</td>
                                <td>Negatif</td>
                                <td>Negatif</td>
                                <td>YalancÄ± pozitif EIA</td>
                            </tr>
                            <tr>
                                <td>Negatif</td>
                                <td>Pozitif</td>
                                <td>-</td>
                                <td>YalancÄ± pozitif RPR</td>
                            </tr>
                        </tbody>
                    </table>

                    <div class="alert-box alert-box--info">
                        <div class="alert-box__icon"><i class="fas fa-list"></i></div>
                        <div class="alert-box__content">
                            <strong>RPR/VDRL YalancÄ± Pozitiflik Nedenleri:</strong><br>
                            â€¢ Gebelik, OtoimmÃ¼n hastalÄ±klar (SLE, APS)<br>
                            â€¢ IV ilaÃ§ kullanÄ±mÄ±, Ä°leri yaÅŸ<br>
                            â€¢ DiÄŸer enfeksiyonlar: TÃ¼berkÃ¼loz, EBV, Hepatit, Malaria<br>
                            â€¢ <strong>HafÄ±za kodu: "GODA"</strong> - Gebelik, OtoimmÃ¼n, Drugs, Age
                        </div>
                    </div>
                `
            },
            {
                title: "TORCH Paneli",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-baby"></i> TORCH Etkenleri</h4>
                        <ul class="feature-list">
                            <li><strong>T</strong> - Toxoplasma gondii</li>
                            <li><strong>O</strong> - Other (Sifiliz, VZV, Parvovirus B19, Listeria)</li>
                            <li><strong>R</strong> - Rubella (KÄ±zamÄ±kÃ§Ä±k)</li>
                            <li><strong>C</strong> - Cytomegalovirus (CMV)</li>
                            <li><strong>H</strong> - Herpes simplex virus (HSV)</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>IgM</th>
                                <th>IgG</th>
                                <th>Yorum</th>
                                <th>Gebelikte YaklaÅŸÄ±m</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Negatif</td>
                                <td>Negatif</td>
                                <td>DuyarlÄ± (naif)</td>
                                <td>Korunma Ã¶nerileri, takip</td>
                            </tr>
                            <tr>
                                <td><strong>Pozitif</strong></td>
                                <td>Negatif</td>
                                <td>Ã‡ok erken akut enfeksiyon</td>
                                <td>2 hafta sonra tekrar test</td>
                            </tr>
                            <tr>
                                <td><strong>Pozitif</strong></td>
                                <td><strong>Pozitif</strong></td>
                                <td>Akut veya yakÄ±n geÃ§miÅŸ</td>
                                <td><strong>IgG Avidite testi yap!</strong></td>
                            </tr>
                            <tr>
                                <td>Negatif</td>
                                <td><strong>Pozitif</strong></td>
                                <td>GeÃ§irilmiÅŸ enfeksiyon / BaÄŸÄ±ÅŸÄ±k</td>
                                <td>Risk yok (genellikle)</td>
                            </tr>
                        </tbody>
                    </table>

                    <div class="alert-box alert-box--danger">
                        <div class="alert-box__icon"><i class="fas fa-exclamation-circle"></i></div>
                        <div class="alert-box__content">
                            <strong>IgG Avidite Testi - Kritik Ã–nemi:</strong><br>
                            â€¢ <strong>DÃ¼ÅŸÃ¼k avidite (&lt;30%):</strong> Son 3-4 ay iÃ§inde enfeksiyon â†’ <strong>Fetal risk YÃœKSEK</strong><br>
                            â€¢ <strong>YÃ¼ksek avidite (&gt;60%):</strong> 3-4 aydan eski enfeksiyon â†’ Fetal risk dÃ¼ÅŸÃ¼k<br>
                            â€¢ IgM (+) IgG (+) durumunda enfeksiyonun zamanlamasÄ±nÄ± belirlemek iÃ§in ÅART!
                        </div>
                    </div>

                    <h4><i class="fas fa-biohazard"></i> Konjenital Enfeksiyon BulgularÄ±</h4>
                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Etken</th>
                                <th>Karakteristik Bulgular</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Toxoplasma</strong></td>
                                <td>Hidrosefali, intrakraniyal kalsifikasyon (yaygÄ±n), koryoretinit</td>
                            </tr>
                            <tr>
                                <td><strong>Rubella</strong></td>
                                <td>Katarakt, saÄŸÄ±rlÄ±k, PDA, "blueberry muffin" dÃ¶kÃ¼ntÃ¼</td>
                            </tr>
                            <tr>
                                <td><strong>CMV</strong></td>
                                <td>PeriventrikÃ¼ler kalsifikasyon, mikrosefali, sensÃ¶rinÃ¶ral saÄŸÄ±rlÄ±k</td>
                            </tr>
                            <tr>
                                <td><strong>HSV</strong></td>
                                <td>VezikÃ¼l, ensefalit, DIC (doÄŸum kanalÄ±ndan bulaÅŸ)</td>
                            </tr>
                            <tr>
                                <td><strong>Sifiliz</strong></td>
                                <td>Hutchinson triadÄ±, sabre tibia, saddle nose</td>
                            </tr>
                        </tbody>
                    </table>
                `
            },
            {
                title: "Bruselloz Serolojisi",
                content: `
                    <div class="highlight-box highlight-box--secondary">
                        <h4><i class="fas fa-flask"></i> Serolojik Testler</h4>
                        <ul class="feature-list">
                            <li><strong>Rose Bengal:</strong> HÄ±zlÄ± tarama testi (lam aglÃ¼tinasyon)</li>
                            <li><strong>Standart TÃ¼p AglÃ¼tinasyon (STA/Wright):</strong> Titre â‰¥1/160 anlamlÄ±</li>
                            <li><strong>Coombs Testi:</strong> Blokan antikorlarÄ± tespit eder (kronik bruselloz)</li>
                            <li><strong>2-Merkaptoetanol (2-ME):</strong> IgM'i inaktive eder, IgG kalÄ±r</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <div class="alert-box__icon"><i class="fas fa-search"></i></div>
                        <div class="alert-box__content">
                            <strong>Prozon Fenomeni:</strong><br>
                            YÃ¼ksek antikor konsantrasyonunda aglÃ¼tinasyonun gÃ¶rÃ¼lmemesi. DÃ¼ÅŸÃ¼k dilÃ¼syonlarda yalancÄ± negatiflik yapar!<br>
                            <strong>Ã‡Ã¶zÃ¼m:</strong> Serumu daha fazla dilÃ¼e et veya Coombs testi kullan.
                        </div>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Test Sonucu</th>
                                <th>Yorum</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>STA â‰¥1/160</td>
                                <td>Aktif enfeksiyon dÃ¼ÅŸÃ¼ndÃ¼rÃ¼r</td>
                            </tr>
                            <tr>
                                <td>STA (+), Coombs (+), STA &gt; Coombs titre</td>
                                <td>Akut bruselloz</td>
                            </tr>
                            <tr>
                                <td>STA (-/dÃ¼ÅŸÃ¼k), Coombs (+) yÃ¼ksek titre</td>
                                <td><strong>Kronik bruselloz</strong> (blokan antikor)</td>
                            </tr>
                            <tr>
                                <td>2-ME sonrasÄ± titre â‰¥4 kat dÃ¼ÅŸÃ¼ÅŸ</td>
                                <td>IgM baskÄ±n (akut)</td>
                            </tr>
                            <tr>
                                <td>2-ME sonrasÄ± titre deÄŸiÅŸmez</td>
                                <td>IgG baskÄ±n (kronik veya tedavi gÃ¶rmÃ¼ÅŸ)</td>
                            </tr>
                        </tbody>
                    </table>

                    <div class="alert-box alert-box--info">
                        <div class="alert-box__icon"><i class="fas fa-lightbulb"></i></div>
                        <div class="alert-box__content">
                            <strong>SÄ±nav Ä°pucu - Ã‡apraz Reaksiyon:</strong><br>
                            Brucella ile Ã§apraz reaksiyon veren bakteriler: <strong>Yersinia enterocolitica O:9</strong>, Francisella tularensis, Vibrio cholerae<br>
                            Bu durumda kÃ¼ltÃ¼r veya PCR ile doÄŸrulama gerekir.
                        </div>
                    </div>
                `
            },
            {
                title: "EBV ve Heterofil Antikorlar",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-virus"></i> EBV Serolojik BelirteÃ§ler</h4>
                        <ul class="feature-list">
                            <li><strong>Heterofil antikor (Monospot):</strong> HÄ±zlÄ± tarama, Ã§ocuklarda duyarlÄ±lÄ±k dÃ¼ÅŸÃ¼k</li>
                            <li><strong>VCA IgM:</strong> Akut enfeksiyon (4-8 hafta pozitif kalÄ±r)</li>
                            <li><strong>VCA IgG:</strong> GeÃ§irilmiÅŸ enfeksiyon (Ã¶mÃ¼r boyu pozitif)</li>
                            <li><strong>EA (Early Antigen):</strong> Akut/reaktivasyon (kronik aktif EBV'de yÃ¼ksek)</li>
                            <li><strong>EBNA IgG:</strong> GeÃ§ dÃ¶nem, iyileÅŸme (6-12 hafta sonra pozitifleÅŸir)</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Klinik Durum</th>
                                <th>VCA IgM</th>
                                <th>VCA IgG</th>
                                <th>EBNA IgG</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>DuyarlÄ± (naif)</td>
                                <td>-</td>
                                <td>-</td>
                                <td>-</td>
                            </tr>
                            <tr>
                                <td><strong>Akut enfeksiyon</strong></td>
                                <td><strong>+</strong></td>
                                <td>+/-</td>
                                <td><strong>-</strong></td>
                            </tr>
                            <tr>
                                <td>YakÄ±n geÃ§miÅŸ enfeksiyon</td>
                                <td>+/-</td>
                                <td>+</td>
                                <td>+/-</td>
                            </tr>
                            <tr>
                                <td><strong>GeÃ§irilmiÅŸ enfeksiyon</strong></td>
                                <td>-</td>
                                <td><strong>+</strong></td>
                                <td><strong>+</strong></td>
                            </tr>
                        </tbody>
                    </table>

                    <div class="alert-box alert-box--danger">
                        <div class="alert-box__icon"><i class="fas fa-child"></i></div>
                        <div class="alert-box__content">
                            <strong>Pediatrik Dikkat:</strong><br>
                            4 yaÅŸ altÄ± Ã§ocuklarda heterofil antikor testi %50'ye kadar yalancÄ± negatif olabilir!<br>
                            <strong>Ã‡Ã¶zÃ¼m:</strong> Ã‡ocuklarda spesifik EBV serolojisi (VCA IgM/IgG, EBNA) kullan.
                        </div>
                    </div>
                `
            },
            {
                title: "Ã–zel Durumlar ve Ä°leri Testler",
                content: `
                    <h4><i class="fas fa-procedures"></i> Lyme HastalÄ±ÄŸÄ± - 2 BasamaklÄ± Test</h4>
                    <div class="highlight-box highlight-box--secondary">
                        <ol class="feature-list">
                            <li><strong>1. Basamak:</strong> EIA veya IFA (tarama)</li>
                            <li><strong>2. Basamak:</strong> Western Blot ile doÄŸrulama (IgM ve/veya IgG)</li>
                        </ol>
                        <p><strong>Not:</strong> Erken dÃ¶nemde (eritema migrans) seroloji negatif olabilir - klinik tanÄ± yeterli!</p>
                    </div>

                    <h4><i class="fas fa-lungs"></i> Q AteÅŸi (Coxiella burnetii) - Faz Antijenleri</h4>
                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Antijen</th>
                                <th>Yorum</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Faz II antikoru yÃ¼ksek</strong></td>
                                <td>Akut Q ateÅŸi</td>
                            </tr>
                            <tr>
                                <td><strong>Faz I IgG â‰¥1:800</strong></td>
                                <td>Kronik Q ateÅŸi (endokardit)</td>
                            </tr>
                        </tbody>
                    </table>

                    <h4><i class="fas fa-baby"></i> HIV (+) Anne BebeÄŸi Takibi</h4>
                    <div class="alert-box alert-box--warning">
                        <div class="alert-box__icon"><i class="fas fa-exclamation-triangle"></i></div>
                        <div class="alert-box__content">
                            <strong>Antikor testleri 18 aya kadar KULLANILAMAZ!</strong><br>
                            Maternal IgG antikorlarÄ± plasentadan geÃ§er ve 18 aya kadar bebekte pozitif kalabilir.<br><br>
                            <strong>TanÄ±:</strong> HIV DNA PCR veya HIV RNA<br>
                            â€¢ DoÄŸumda, 14-21. gÃ¼n, 1-2. ay, 4-6. ayda test<br>
                            â€¢ 2 negatif virolojik test = enfeksiyon dÄ±ÅŸlanÄ±r
                        </div>
                    </div>

                    <h4><i class="fas fa-procedures"></i> Konjenital Sifiliz TanÄ±sÄ±</h4>
                    <ul class="feature-list">
                        <li>Bebek RPR titresi anne titresinin <strong>â‰¥4 kat</strong> yÃ¼ksekse â†’ Konjenital sifiliz</li>
                        <li>Bebekte <strong>IgM FTA-ABS (+)</strong> â†’ Bebekte aktif enfeksiyon (IgM plasentayÄ± geÃ§mez)</li>
                        <li>BOS'ta <strong>VDRL (+)</strong> â†’ NÃ¶rositiliz</li>
                    </ul>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Ã–zet",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-star"></i> En SÄ±k Sorulan EÅŸleÅŸmeler</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>Antikor/Patern</th>
                                    <th>HastalÄ±k</th>
                                    <th>SÄ±nav Ä°pucu</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>HBsAg (-), Anti-HBs (+), Anti-HBc (-)</td>
                                    <td><strong>AÅŸÄ±lÄ± birey</strong></td>
                                </tr>
                                <tr>
                                    <td>HBsAg (-), Anti-HBs (-), Anti-HBc IgM (+)</td>
                                    <td><strong>Pencere dÃ¶nemi</strong></td>
                                </tr>
                                <tr>
                                    <td>Anti-HCV (+), HCV RNA (-)</td>
                                    <td><strong>GeÃ§irilmiÅŸ HCV veya yalancÄ± (+)</strong></td>
                                </tr>
                                <tr>
                                    <td>HIV 4. nesil (+), AyÄ±rÄ±m belirsiz, RNA (+)</td>
                                    <td><strong>Akut HIV (serokonversiyon)</strong></td>
                                </tr>
                                <tr>
                                    <td>EIA (+), RPR (-), TPPA (+)</td>
                                    <td><strong>GeÃ§irilmiÅŸ tedavi edilmiÅŸ sifiliz</strong></td>
                                </tr>
                                <tr>
                                    <td>IgM (+), IgG (+), DÃ¼ÅŸÃ¼k avidite</td>
                                    <td><strong>Son 3 ayda primer enfeksiyon</strong></td>
                                </tr>
                                <tr>
                                    <td>STA (-), Coombs (+)</td>
                                    <td><strong>Kronik bruselloz</strong></td>
                                </tr>
                                <tr>
                                    <td>VCA IgM (+), EBNA (-)</td>
                                    <td><strong>Akut EBV</strong></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">Mega HafÄ±za KodlarÄ±</p>
                        <p class="mnemonic-box__text">
                            <strong>"HoBeNÃ¼SePe"</strong> â†’ ANA paternleri<br>
                            <strong>"c-PR3-Wegener, p-MPO-Mikro"</strong> â†’ ANCA<br>
                            <strong>"Sm = SLE Marker"</strong> â†’ En spesifik<br>
                            <strong>"dsDNA = Disease DNA"</strong> â†’ Aktivite takibi<br>
                            <strong>"AMA = Always Means PBC Almost"</strong> â†’ %95 Ã¶zgÃ¼l<br>
                            <strong>"CREST = Centromer"</strong> â†’ 46 nokta
                        </p>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>TUZAK SORULAR:</strong><br><br>
                            â€¢ "ANA negatif SLE olabilir mi?" â†’ <strong>EVET!</strong> Anti-SSA/Ro (+) iste<br>
                            â€¢ "p-ANCA pozitif ama MPO negatif?" â†’ Atipik ANCA, Ä°BH dÃ¼ÅŸÃ¼n<br>
                            â€¢ "Homojen ANA + dsDNA(-) + Histon(+)?" â†’ <strong>Ä°laca baÄŸlÄ± lupus</strong><br>
                            â€¢ "46 ayrÄ±k nokta IIF'de?" â†’ <strong>Anti-sentromer (CREST)</strong><br>
                            â€¢ "Crithidia luciliae ne iÃ§in?" â†’ <strong>Anti-dsDNA</strong> (en spesifik yÃ¶ntem)
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">ğŸ’¡</span>
                        <p class="alert-box__text"><strong>Pratik SÄ±nav YaklaÅŸÄ±mÄ±:</strong><br><br>
                            <strong>Soru:</strong> "55 yaÅŸÄ±nda kadÄ±n, ANA 1:320 homojen patern, eklem aÄŸrÄ±sÄ±..."<br>
                            <strong>DÃ¼ÅŸÃ¼n:</strong> Homojen = dsDNA veya Histon<br>
                            <strong>Ä°ste:</strong> Anti-dsDNA, Anti-Histon, C3, C4<br>
                            <strong>DeÄŸerlendir:</strong> dsDNA(+) + dÃ¼ÅŸÃ¼k kompleman = aktif SLE
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li><b>Soru tipi:</b> "Homojen ANA + Anti-dsDNA (+)?" â†’ SLE</li>
                        <li><b>Soru tipi:</b> "Benekli ANA + Anti-SSA (+)?" â†’ SjÃ¶gren veya SLE</li>
                        <li><b>Soru tipi:</b> "NÃ¼kleolar ANA?" â†’ Skleroderma</li>
                        <li><b>Soru tipi:</b> "c-ANCA + sinÃ¼zit + hemoptizi + hematÃ¼ri?" â†’ GPA</li>
                        <li><b>Soru tipi:</b> "p-ANCA + RPGN?" â†’ MPA veya anti-GBM</li>
                        <li><b>Soru tipi:</b> "KaÅŸÄ±ntÄ± + ALP yÃ¼ksek + AMA (+)?" â†’ PBC</li>
                    </ul>
                `
            }
        ]
    },
    {
        id: 7,
        title: "Ä°ndirekt Ä°mmÃ¼nfloresan (IIF) Testleri",
        subtitle: "ANA Paternleri, ANCA ve Klinik Korelasyonlar",
        category: "laboratuvar",
        icon: "fa-microscope",
        color: "#06b6d4",
        lastUpdated: "2024-01-20",
        readTime: "25 dk",
        summary: "Ä°ndirekt immÃ¼nfloresan mikroskobi ile deÄŸerlendirilen otoantikor testleri. ANA paternleri ve hastalÄ±k korelasyonlarÄ±, ANCA tipleri, anti-dsDNA ve diÄŸer spesifik antikorlarÄ±n klinik yorumu.",
        tags: ["IIF", "ANA", "ANCA", "Otoantikor", "Floresan Mikroskopi", "OtoimmÃ¼n HastalÄ±k"],
        sections: [
            {
                title: "IIF Temel Prensipler",
                icon: "fas fa-lightbulb",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-microscope"></i> Ä°ndirekt Ä°mmÃ¼nfloresan YÃ¶ntemi</h4>
                        <p>Ä°ki aÅŸamalÄ± antikor tespit yÃ¶ntemidir:</p>
                        <ol class="feature-list">
                            <li><strong>1. AÅŸama:</strong> Hasta serumu + Substrat (HEp-2 hÃ¼cresi, nÃ¶trofil vb.) â†’ Antikor baÄŸlanmasÄ±</li>
                            <li><strong>2. AÅŸama:</strong> Floresan iÅŸaretli anti-human IgG eklenir â†’ UV'de parlama</li>
                        </ol>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">IIF AvantajlarÄ± ve DezavantajlarÄ±</h4>
                        <table class="article-table">
                            <tr>
                                <th>Avantajlar</th>
                                <th>Dezavantajlar</th>
                            </tr>
                            <tr>
                                <td>
                                    â€¢ YÃ¼ksek duyarlÄ±lÄ±k<br>
                                    â€¢ Patern analizi mÃ¼mkÃ¼n<br>
                                    â€¢ Titre tayini yapÄ±labilir<br>
                                    â€¢ Tarama testi olarak ideal
                                </td>
                                <td>
                                    â€¢ Subjektif deÄŸerlendirme<br>
                                    â€¢ Deneyimli personel gerektirir<br>
                                    â€¢ Antijen spesifikliÄŸi dÃ¼ÅŸÃ¼k<br>
                                    â€¢ DoÄŸrulama testleri gerekli
                                </td>
                            </tr>
                        </table>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">â„¹ï¸</span>
                        <p class="alert-box__text"><strong>Substrat SeÃ§imi:</strong><br>
                            â€¢ <strong>HEp-2 hÃ¼creleri:</strong> ANA testi iÃ§in altÄ±n standart (insan laringeal karsinom)<br>
                            â€¢ <strong>Etanol fikse nÃ¶trofiller:</strong> ANCA testi iÃ§in<br>
                            â€¢ <strong>Crithidia luciliae:</strong> Anti-dsDNA iÃ§in spesifik<br>
                            â€¢ <strong>Maymun Ã¶zofagusu:</strong> Anti-dÃ¼z kas, anti-mitokondriyal Ab
                        </p>
                    </div>
                `
            },
            {
                title: "ANA (AntinÃ¼kleer Antikor) Testi",
                icon: "fas fa-atom",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-star"></i> ANA Testi Genel Bilgiler</h4>
                        <ul class="feature-list">
                            <li><strong>Substrat:</strong> HEp-2 hÃ¼creleri (mitotik hÃ¼creler iÃ§erir - Ã¶nemli!)</li>
                            <li><strong>Pozitiflik eÅŸiÄŸi:</strong> Genellikle â‰¥1:80 veya â‰¥1:160 (laboratuvara gÃ¶re deÄŸiÅŸir)</li>
                            <li><strong>Tarama testi:</strong> SLE iÃ§in %95-99 duyarlÄ±lÄ±k, dÃ¼ÅŸÃ¼k Ã¶zgÃ¼llÃ¼k</li>
                            <li><strong>SaÄŸlÄ±klÄ± popÃ¼lasyonda:</strong> %5-15 dÃ¼ÅŸÃ¼k titrede pozitif olabilir</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>KRÄ°TÄ°K:</strong> ANA negatif ise SLE tanÄ±sÄ± hemen hemen dÄ±ÅŸlanÄ±r! (%95-99 duyarlÄ±lÄ±k)<br>
                        Ancak ANA pozitif ise SLE demek DEÄÄ°LDÄ°R - Ã¶zgÃ¼llÃ¼k dÃ¼ÅŸÃ¼ktÃ¼r, patern ve doÄŸrulama testleri gerekir.
                        </p>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">ANA YaklaÅŸÄ±m AlgoritmasÄ±</p>
                        <p class="mnemonic-box__text">ANA â†’ PATERN â†’ DOÄRULAMA â†’ KLÄ°NÄ°K</p>
                        <p class="mnemonic-box__hint">
                            1) ANA titre ve pozitiflik<br>
                            2) Patern tanÄ±mlama (Homojen, Benekli, vb.)<br>
                            3) Spesifik antikor doÄŸrulama (ELISA, immunoblot)<br>
                            4) Klinik korelasyon
                        </p>
                    </div>
                `
            },
            {
                title: "ANA Paternleri ve Klinik Korelasyonlar",
                icon: "fas fa-th",
                content: `
                    <div class="highlight-box highlight-box--secondary">
                        <h4><i class="fas fa-eye"></i> Temel ANA Paternleri</h4>
                        <p>ICAP (International Consensus on ANA Patterns) sÄ±nÄ±flamasÄ±na gÃ¶re ana paternler:</p>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Patern</th>
                                <th>GÃ¶rÃ¼nÃ¼m</th>
                                <th>Hedef Antijenler</th>
                                <th>Ä°liÅŸkili HastalÄ±klar</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>Homojen (DiffÃ¼z)</strong></td>
                                <td>TÃ¼m nÃ¼kleus uniform boyalÄ±, mitotik kromozomlar (+)</td>
                                <td>dsDNA, Histonlar, NÃ¼kleozom</td>
                                <td><strong>SLE</strong>, Ä°laca baÄŸlÄ± lupus</td>
                            </tr>
                            <tr>
                                <td><strong>Benekli (Speckled)</strong></td>
                                <td>NÃ¼kleus iÃ§inde benekler, mitotik kromozom (-)</td>
                                <td>Sm, RNP, SSA/Ro, SSB/La, Scl-70</td>
                                <td><strong>SLE, SjÃ¶gren, Skleroderma, MCTD</strong></td>
                            </tr>
                            <tr>
                                <td><strong>NÃ¼kleolar</strong></td>
                                <td>Sadece nÃ¼kleolus boyalÄ± (1-5 parlak nokta)</td>
                                <td>PM-Scl, RNA polimeraz, Fibrillarin</td>
                                <td><strong>Skleroderma</strong>, Polimiyozit</td>
                            </tr>
                            <tr>
                                <td><strong>Sentromer</strong></td>
                                <td>46 ayrÄ±k nokta (kromozom sayÄ±sÄ± kadar)</td>
                                <td>CENP-A, CENP-B, CENP-C</td>
                                <td><strong>Limitli Skleroderma (CREST)</strong></td>
                            </tr>
                            <tr>
                                <td><strong>Periferik (Rim)</strong></td>
                                <td>NÃ¼kleer membran boyalÄ±, halka ÅŸeklinde</td>
                                <td>dsDNA, Lamin, Nuclear pore</td>
                                <td><strong>SLE</strong> (yÃ¼ksek Ã¶zgÃ¼llÃ¼k)</td>
                            </tr>
                        </tbody>
                    </table>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">Patern HafÄ±za Kodu</p>
                        <p class="mnemonic-box__text">"HoBeNÃ¼SePe"</p>
                        <p class="mnemonic-box__hint">
                            <strong>Ho</strong>mojen â†’ SLE (dsDNA, Histon)<br>
                            <strong>Be</strong>nekli â†’ KarÄ±ÅŸÄ±k (Sm, RNP, SSA, SSB)<br>
                            <strong>NÃ¼</strong>kleolar â†’ Skleroderma<br>
                            <strong>Se</strong>ntromer â†’ CREST (46 nokta!)<br>
                            <strong>Pe</strong>riferik â†’ SLE (dsDNA, en Ã¶zgÃ¼l)
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">ğŸ’¡</span>
                        <p class="alert-box__text"><strong>SÄ±nav Ä°pucu - Mitotik HÃ¼crelere Dikkat!</strong><br>
                            â€¢ <strong>Homojen:</strong> Mitotik kromozomlar BOYANIR<br>
                            â€¢ <strong>Benekli:</strong> Mitotik kromozomlar BOYANMAZ<br>
                            â€¢ <strong>Sentromer:</strong> Mitotik hÃ¼crelerde 46 AYRIK NOKTA gÃ¶rÃ¼lÃ¼r
                        </p>
                    </div>
                `
            },
            {
                title: "Spesifik Antikorlar ve HastalÄ±k Ä°liÅŸkileri",
                icon: "fas fa-link",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-bullseye"></i> SLE Ä°liÅŸkili Antikorlar</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>Antikor</th>
                                    <th>DuyarlÄ±lÄ±k</th>
                                    <th>Ã–zgÃ¼llÃ¼k</th>
                                    <th>Klinik Ã–nemi</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><strong>Anti-dsDNA</strong></td>
                                    <td>%60-70</td>
                                    <td><strong>%95+</strong></td>
                                    <td>HastalÄ±k aktivitesi, lupus nefriti</td>
                                </tr>
                                <tr>
                                    <td><strong>Anti-Sm</strong></td>
                                    <td>%25-30</td>
                                    <td><strong>%99+</strong></td>
                                    <td>SLE iÃ§in EN SPESÄ°FÄ°K! TanÄ± koydurucu</td>
                                </tr>
                                <tr>
                                    <td><strong>Anti-Histon</strong></td>
                                    <td>%50-70</td>
                                    <td>DÃ¼ÅŸÃ¼k</td>
                                    <td><strong>Ä°laca baÄŸlÄ± lupus</strong> (%95+)</td>
                                </tr>
                                <tr>
                                    <td><strong>Anti-RNP</strong></td>
                                    <td>%30-40</td>
                                    <td>DÃ¼ÅŸÃ¼k</td>
                                    <td>MCTD (yÃ¼ksek titrede)</td>
                                </tr>
                                <tr>
                                    <td><strong>Anti-SSA/Ro</strong></td>
                                    <td>%30-40</td>
                                    <td>Orta</td>
                                    <td>Neonatal lupus, kalp bloÄŸu, ANA(-) SLE</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>KRÄ°TÄ°K - ANA Negatif SLE:</strong><br>
                            %5 SLE hastasÄ±nda ANA negatif olabilir!<br>
                            BunlarÄ±n Ã§oÄŸunda <strong>Anti-SSA/Ro (+)</strong> bulunur.<br>
                            Klinik ÅŸÃ¼phe yÃ¼ksekse Anti-SSA/Ro mutlaka istenmelidir!
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">DiÄŸer OtoimmÃ¼n HastalÄ±klarda Antikorlar</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>HastalÄ±k</th>
                                    <th>Karakteristik Antikor</th>
                                    <th>Not</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><strong>SjÃ¶gren Sendromu</strong></td>
                                    <td>Anti-SSA/Ro, Anti-SSB/La</td>
                                    <td>SSB daha spesifik</td>
                                </tr>
                                <tr>
                                    <td><strong>DiffÃ¼z Skleroderma</strong></td>
                                    <td>Anti-Scl-70 (Topoizomeraz I)</td>
                                    <td>AkciÄŸer tutulumu riski</td>
                                </tr>
                                <tr>
                                    <td><strong>Limitli Skleroderma (CREST)</strong></td>
                                    <td>Anti-Sentromer</td>
                                    <td>Pulmoner HT riski</td>
                                </tr>
                                <tr>
                                    <td><strong>MCTD</strong></td>
                                    <td>Anti-U1 RNP (yÃ¼ksek titre)</td>
                                    <td>Ä°ZOLE yÃ¼ksek RNP</td>
                                </tr>
                                <tr>
                                    <td><strong>Polimiyozit</strong></td>
                                    <td>Anti-Jo-1 (Histidil-tRNA sentetaz)</td>
                                    <td>Antisendronik sendrom, ILD</td>
                                </tr>
                                <tr>
                                    <td><strong>Dermatomiyozit</strong></td>
                                    <td>Anti-Mi-2</td>
                                    <td>Ä°yi prognoz</td>
                                </tr>
                                <tr>
                                    <td><strong>Ä°laca BaÄŸlÄ± Lupus</strong></td>
                                    <td>Anti-Histon</td>
                                    <td>dsDNA genellikle (-)</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">Ã–zgÃ¼llÃ¼k SÄ±ralamasÄ± (SLE iÃ§in)</p>
                        <p class="mnemonic-box__text">"Sm > dsDNA > RNP"</p>
                        <p class="mnemonic-box__hint">
                            Anti-Sm: EN SPESÄ°FÄ°K (%99), duyarlÄ±lÄ±k dÃ¼ÅŸÃ¼k<br>
                            Anti-dsDNA: Ã‡ok spesifik (%95), aktivite takibi<br>
                            Anti-RNP: Daha az spesifik, MCTD'de yÃ¼ksek
                        </p>
                    </div>
                `
            },
            {
                title: "Anti-dsDNA Testi",
                icon: "fas fa-dna",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-vial"></i> Anti-dsDNA Test YÃ¶ntemleri</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>YÃ¶ntem</th>
                                    <th>Ã–zellik</th>
                                    <th>Avantaj/Dezavantaj</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><strong>Crithidia luciliae IIF</strong></td>
                                    <td>Kinetoplast boyanÄ±r</td>
                                    <td>EN SPESÄ°FÄ°K (altÄ±n standart), dÃ¼ÅŸÃ¼k duyarlÄ±lÄ±k</td>
                                </tr>
                                <tr>
                                    <td><strong>Farr Assay</strong></td>
                                    <td>Radyoaktif dsDNA</td>
                                    <td>YÃ¼ksek Ã¶zgÃ¼llÃ¼k, radyasyon riski</td>
                                </tr>
                                <tr>
                                    <td><strong>ELISA</strong></td>
                                    <td>Rekombinant/native dsDNA</td>
                                    <td>Kolay, yalancÄ± (+) olabilir</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">ğŸ’¡</span>
                        <p class="alert-box__text"><strong>Crithidia luciliae Nedir?</strong><br>
                            Hemoflagelat bir protozoon. KinetoplastÄ± saf dsDNA iÃ§erir (histon iÃ§ermez!).<br>
                            Bu nedenle anti-histon antikorlarÄ± reaksiyon vermez â†’ <strong>saf dsDNA antikorlarÄ±nÄ± tespit eder</strong>
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Anti-dsDNA Klinik KullanÄ±mÄ±</h4>
                        <ul class="feature-list">
                            <li><b>SLE TanÄ±sÄ±:</b> YÃ¼ksek Ã¶zgÃ¼llÃ¼k (%95+), tanÄ± kriterlerinde yer alÄ±r</li>
                            <li><b>HastalÄ±k Aktivitesi:</b> Titre ile aktivite paralel seyreder</li>
                            <li><b>Lupus Nefriti:</b> Anti-dsDNA (+) ve kompleman dÃ¼ÅŸÃ¼klÃ¼ÄŸÃ¼ â†’ Nefrit riski â†‘</li>
                            <li><b>Takip:</b> 3-6 ayda bir titre kontrolÃ¼</li>
                        </ul>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>Anti-dsDNA Titre Yorumu:</strong><br>
                            â€¢ Titre â†‘ + Kompleman â†“ â†’ Aktif hastalÄ±k, nefrit riski<br>
                            â€¢ Titre â†‘ + Klinik kÃ¶tÃ¼leÅŸme â†’ Alevlenme<br>
                            â€¢ DÃ¼ÅŸÃ¼k/stabil titre â†’ Remisyon
                        </p>
                    </div>
                `
            },
            {
                title: "ANCA (Anti-NÃ¶trofil Sitoplazmik Antikor)",
                icon: "fas fa-shield-virus",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-microscope"></i> ANCA IIF Paternleri</h4>
                        <p>Etanol fikse nÃ¶trofiller Ã¼zerinde deÄŸerlendirilir:</p>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>IIF Patern</th>
                                <th>GÃ¶rÃ¼nÃ¼m</th>
                                <th>Hedef Antijen</th>
                                <th>Ä°liÅŸkili HastalÄ±k</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>c-ANCA (Sitoplazmik)</strong></td>
                                <td>GranÃ¼ler sitoplazmik boyanma, merkezi yoÄŸunluk</td>
                                <td><strong>PR3</strong> (Proteinaz 3)</td>
                                <td><strong>GPA (Wegener)</strong></td>
                            </tr>
                            <tr>
                                <td><strong>p-ANCA (PerinÃ¼kleer)</strong></td>
                                <td>NÃ¼kleus Ã§evresinde yoÄŸunlaÅŸma (artefakt)</td>
                                <td><strong>MPO</strong> (Miyeloperoksidaz)</td>
                                <td><strong>MPA, EGPA (Churg-Strauss), Renal vaskÃ¼lit</strong></td>
                            </tr>
                            <tr>
                                <td><strong>Atipik ANCA</strong></td>
                                <td>c ve p arasÄ± veya farklÄ± patern</td>
                                <td>Elastaz, Laktoferrin, BPI vb.</td>
                                <td>Ä°BH, OtoimmÃ¼n hepatit, Ä°laÃ§ iliÅŸkili</td>
                            </tr>
                        </tbody>
                    </table>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">ANCA HafÄ±za Kodu</p>
                        <p class="mnemonic-box__text">"c-PR3-Wegener" vs "p-MPO-Mikro"</p>
                        <p class="mnemonic-box__hint">
                            <strong>c-ANCA = PR3 = GPA (Wegener)</strong> â†’ "C" harfi "Cytoplasmic" ve "PR3"<br>
                            <strong>p-ANCA = MPO = MPA/EGPA</strong> â†’ "P" harfi "Perinuclear" ve "MPO"
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">ANCA-Ä°liÅŸkili VaskÃ¼litler (AAV)</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>HastalÄ±k</th>
                                    <th>ANCA</th>
                                    <th>Karakteristik Bulgu</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><strong>GPA (Wegener)</strong></td>
                                    <td>c-ANCA/PR3 (%90)</td>
                                    <td>Ãœst solunum + Alt solunum + BÃ¶brek (triad)</td>
                                </tr>
                                <tr>
                                    <td><strong>MPA</strong></td>
                                    <td>p-ANCA/MPO (%60-70)</td>
                                    <td>Pulmoner-renal sendrom, palpable purpura</td>
                                </tr>
                                <tr>
                                    <td><strong>EGPA (Churg-Strauss)</strong></td>
                                    <td>p-ANCA/MPO (%40-60)</td>
                                    <td>AstÄ±m + Eozinofili + VaskÃ¼lit</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>ANCA Test AlgoritmasÄ± (ACR/EULAR 2017):</strong><br>
                            1. <strong>IIF ile tarama</strong> (c-ANCA veya p-ANCA paterni)<br>
                            2. <strong>ELISA/Ä°mmunoblot ile doÄŸrulama</strong> (PR3 veya MPO spesifik)<br>
                            <br>
                            <strong>YENÄ° Ã–NERÄ°:</strong> YÃ¼ksek klinik ÅŸÃ¼phede <strong>direkt PR3/MPO ELISA</strong> ile baÅŸlanabilir (IIF atlanabilir)
                        </p>
                    </div>

                    <div class="alert-box alert-box--warning">
                        <span class="alert-box__icon">âš ï¸</span>
                        <p class="alert-box__text"><strong>p-ANCA TuzaÄŸÄ±:</strong><br>
                            p-ANCA paterni bir <strong>artefakttÄ±r</strong> - etanol fiksasyonu sÄ±rasÄ±nda pozitif yÃ¼klÃ¼ granÃ¼l proteinleri negatif yÃ¼klÃ¼ nÃ¼kleusa Ã§ekilir.<br>
                            <strong>ANA pozitifliÄŸi p-ANCA'yÄ± taklit edebilir!</strong><br>
                            Ã‡Ã¶zÃ¼m: Formalin fikse nÃ¶trofiller veya ELISA ile doÄŸrulama
                        </p>
                    </div>
                `
            },
            {
                title: "DiÄŸer IIF Testleri",
                icon: "fas fa-flask",
                content: `
                    <div class="sub-section">
                        <h4 class="sub-section__title">Anti-GBM (GlomerÃ¼ler Bazal Membran)</h4>
                        <ul class="feature-list">
                            <li><b>Substrat:</b> Maymun/insan bÃ¶brek dokusu</li>
                            <li><b>Patern:</b> GlomerÃ¼ler kapiller duvarÄ±nda lineer IgG birikimi</li>
                            <li><b>Ä°liÅŸkili hastalÄ±k:</b> <strong>Goodpasture sendromu</strong> (anti-GBM hastalÄ±ÄŸÄ±)</li>
                            <li><b>Hedef:</b> Tip IV kollajenin Î±3 zinciri</li>
                            <li><b>Klinik:</b> HÄ±zlÄ± ilerleyen GN + Pulmoner hemoraji</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Anti-Mitokondriyal Antikor (AMA)</h4>
                        <ul class="feature-list">
                            <li><b>Substrat:</b> Fare bÃ¶brek/mide, HEp-2</li>
                            <li><b>Patern:</b> Sitoplazmik granÃ¼ler (mitokondri lokalizasyonu)</li>
                            <li><b>Ä°liÅŸkili hastalÄ±k:</b> <strong>Primer Biliyer Kolanjit (PBC)</strong></li>
                            <li><b>Hedef:</b> PDC-E2 (piruvat dehidrojenaz kompleksi)</li>
                            <li><b>Ã–zgÃ¼llÃ¼k:</b> %95+ (PBC iÃ§in tanÄ± koydurucu)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Anti-DÃ¼z Kas Antikoru (ASMA)</h4>
                        <ul class="feature-list">
                            <li><b>Substrat:</b> Fare mide kesiti</li>
                            <li><b>Patern:</b> DÃ¼z kas lifleri boyalÄ± (VGT: Vessel-Gut-Tubule)</li>
                            <li><b>Ä°liÅŸkili hastalÄ±k:</b> <strong>OtoimmÃ¼n Hepatit Tip 1</strong></li>
                            <li><b>Hedef:</b> F-aktin (yÃ¼ksek titrede)</li>
                        </ul>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Anti-LKM (Liver-Kidney Microsomal)</h4>
                        <ul class="feature-list">
                            <li><b>Substrat:</b> Fare karaciÄŸer/bÃ¶brek</li>
                            <li><b>Patern:</b> Proksimal tÃ¼bÃ¼l ve hepatosit sitoplazmasÄ±</li>
                            <li><b>Ä°liÅŸkili hastalÄ±k:</b> <strong>OtoimmÃ¼n Hepatit Tip 2</strong></li>
                            <li><b>Hedef:</b> CYP2D6</li>
                        </ul>
                    </div>

                    <table class="article-table">
                        <thead>
                            <tr>
                                <th>Antikor</th>
                                <th>HastalÄ±k</th>
                                <th>KÄ±sa Not</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>AMA (Anti-M2)</td>
                                <td>Primer Biliyer Kolanjit</td>
                                <td>PDC-E2, %95 Ã¶zgÃ¼l</td>
                            </tr>
                            <tr>
                                <td>ASMA (Anti-aktin)</td>
                                <td>OtoimmÃ¼n Hepatit Tip 1</td>
                                <td>F-aktin paterni</td>
                            </tr>
                            <tr>
                                <td>Anti-LKM1</td>
                                <td>OtoimmÃ¼n Hepatit Tip 2</td>
                                <td>CYP2D6, Ã§ocuklarda</td>
                            </tr>
                            <tr>
                                <td>Anti-GBM</td>
                                <td>Goodpasture</td>
                                <td>Lineer GBM boyama</td>
                            </tr>
                            <tr>
                                <td>Anti-Endomysium (EMA)</td>
                                <td>Ã‡Ã¶lyak HastalÄ±ÄŸÄ±</td>
                                <td>tTG ile doÄŸrula</td>
                            </tr>
                        </tbody>
                    </table>
                `
            },
            {
                title: "IIF Yorumlama AlgoritmasÄ±",
                icon: "fas fa-project-diagram",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-sitemap"></i> ANA Pozitif Hasta - YaklaÅŸÄ±m AlgoritmasÄ±</h4>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">ANA Yorumlama: 5 AdÄ±m</p>
                        <p class="mnemonic-box__text">"TÄ°PPD"</p>
                        <p class="mnemonic-box__hint">
                            <strong>T</strong>itre deÄŸerlendir (â‰¥1:160 anlamlÄ±)<br>
                            <strong>Ä°</strong>F paternini tanÄ±mla<br>
                            <strong>P</strong>aterne gÃ¶re spesifik antikor iste<br>
                            <strong>P</strong>ozitiflik doÄŸrula (ELISA/immunoblot)<br>
                            <strong>D</strong>iÄŸer klinik/lab bulgularÄ± korelesyon
                        </p>
                    </div>

                    <div class="sub-section">
                        <h4 class="sub-section__title">Paterne GÃ¶re Ä°stenecek Testler</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>ANA Paterni</th>
                                    <th>Ä°stenecek Spesifik Antikorlar</th>
                                    <th>DÃ¼ÅŸÃ¼nÃ¼lecek HastalÄ±k</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><strong>Homojen</strong></td>
                                    <td>Anti-dsDNA, Anti-Histon</td>
                                    <td>SLE, Ä°laca baÄŸlÄ± lupus</td>
                                </tr>
                                <tr>
                                    <td><strong>Ä°nce Benekli</strong></td>
                                    <td>Anti-SSA/Ro, Anti-SSB/La</td>
                                    <td>SjÃ¶gren, SLE</td>
                                </tr>
                                <tr>
                                    <td><strong>Kaba Benekli</strong></td>
                                    <td>Anti-Sm, Anti-RNP, Anti-Scl-70</td>
                                    <td>SLE, MCTD, Skleroderma</td>
                                </tr>
                                <tr>
                                    <td><strong>NÃ¼kleolar</strong></td>
                                    <td>Anti-RNA polimeraz, Anti-PM-Scl</td>
                                    <td>Skleroderma, Polimiyozit</td>
                                </tr>
                                <tr>
                                    <td><strong>Sentromer</strong></td>
                                    <td>Anti-CENP-B (ELISA)</td>
                                    <td>Limitli Skleroderma (CREST)</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">ğŸ’¡</span>
                        <p class="alert-box__text"><strong>Klinik Korelasyon Ä°lkeleri:</strong><br>
                            â€¢ YÃ¼ksek titre (â‰¥1:640) â†’ OtoimmÃ¼n hastalÄ±k olasÄ±lÄ±ÄŸÄ± â†‘<br>
                            â€¢ DÃ¼ÅŸÃ¼k titre (1:80-1:160) â†’ SaÄŸlÄ±klÄ± bireylerde de gÃ¶rÃ¼lebilir<br>
                            â€¢ YaÅŸlÄ±larda dÃ¼ÅŸÃ¼k titrede ANA pozitifliÄŸi sÄ±k (%15-25)<br>
                            â€¢ Ä°laÃ§lar (TNF inhibitÃ¶rleri) ANA indÃ¼kleyebilir
                        </p>
                    </div>

                    <div class="highlight-box highlight-box--secondary">
                        <h4><i class="fas fa-exclamation-triangle"></i> ANA Pozitif, Spesifik Antikor Negatif - Ne YapmalÄ±?</h4>
                        <ul class="feature-list">
                            <li>Klinik deÄŸerlendirmeyi tekrarla</li>
                            <li>Titre dÃ¼ÅŸÃ¼kse â†’ Non-spesifik pozitiflik olabilir</li>
                            <li>Takip Ã¶ner (6-12 ay sonra tekrar)</li>
                            <li>Dense Fine Speckled (DFS70) antikorunu deÄŸerlendir â†’ Ä°ZOLE DFS70 (+) ise otoimmÃ¼n hastalÄ±k olasÄ±lÄ±ÄŸÄ± Ã§ok dÃ¼ÅŸÃ¼k!</li>
                        </ul>
                    </div>
                `
            },
            {
                title: "SÄ±nav Ä°Ã§in Kritik Ã–zet",
                icon: "fas fa-graduation-cap",
                content: `
                    <div class="highlight-box highlight-box--primary">
                        <h4><i class="fas fa-star"></i> En SÄ±k Sorulan EÅŸleÅŸmeler</h4>
                        <table class="article-table">
                            <thead>
                                <tr>
                                    <th>Antikor/Patern</th>
                                    <th>HastalÄ±k</th>
                                    <th>SÄ±nav Ä°pucu</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Anti-Sm</td>
                                    <td>SLE</td>
                                    <td><strong>EN SPESÄ°FÄ°K</strong></td>
                                </tr>
                                <tr>
                                    <td>Anti-dsDNA (Crithidia)</td>
                                    <td>SLE + Lupus nefriti</td>
                                    <td>Aktivite takibi</td>
                                </tr>
                                <tr>
                                    <td>Anti-Histon</td>
                                    <td>Ä°laca baÄŸlÄ± lupus</td>
                                    <td>%95, dsDNA (-)</td>
                                </tr>
                                <tr>
                                    <td>Anti-SSA/Ro</td>
                                    <td>SjÃ¶gren, Neonatal lupus</td>
                                    <td>ANA (-) SLE!</td>
                                </tr>
                                <tr>
                                    <td>Anti-Scl-70</td>
                                    <td>DiffÃ¼z Skleroderma</td>
                                    <td>ILD riski</td>
                                </tr>
                                <tr>
                                    <td>Anti-Sentromer</td>
                                    <td>CREST / Limitli SSc</td>
                                    <td>46 nokta</td>
                                </tr>
                                <tr>
                                    <td>Anti-Jo-1</td>
                                    <td>Polimiyozit</td>
                                    <td>Antisentetaz sendrom</td>
                                </tr>
                                <tr>
                                    <td>c-ANCA (PR3)</td>
                                    <td>GPA (Wegener)</td>
                                    <td>Ãœst-alt solunum-bÃ¶brek</td>
                                </tr>
                                <tr>
                                    <td>p-ANCA (MPO)</td>
                                    <td>MPA, EGPA</td>
                                    <td>Pulmoner-renal</td>
                                </tr>
                                <tr>
                                    <td>AMA (Anti-M2)</td>
                                    <td>PBC</td>
                                    <td>PDC-E2</td>
                                </tr>
                                <tr>
                                    <td>ASMA</td>
                                    <td>OÄ°H Tip 1</td>
                                    <td>F-aktin</td>
                                </tr>
                                <tr>
                                    <td>Anti-GBM</td>
                                    <td>Goodpasture</td>
                                    <td>Lineer boyama</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>

                    <div class="mnemonic-box">
                        <p class="mnemonic-box__label">Mega HafÄ±za KodlarÄ±</p>
                        <p class="mnemonic-box__text">
                            <strong>"HoBeNÃ¼SePe"</strong> â†’ ANA paternleri<br>
                            <strong>"c-PR3-Wegener, p-MPO-Mikro"</strong> â†’ ANCA<br>
                            <strong>"Sm = SLE Marker"</strong> â†’ En spesifik<br>
                            <strong>"dsDNA = Disease DNA"</strong> â†’ Aktivite takibi<br>
                            <strong>"AMA = Always Means PBC Almost"</strong> â†’ %95 Ã¶zgÃ¼l<br>
                            <strong>"CREST = Centromer"</strong> â†’ 46 nokta
                        </p>
                    </div>

                    <div class="alert-box alert-box--danger">
                        <span class="alert-box__icon">ğŸš¨</span>
                        <p class="alert-box__text"><strong>TUZAK SORULAR:</strong><br><br>
                            â€¢ "ANA negatif SLE olabilir mi?" â†’ <strong>EVET!</strong> Anti-SSA/Ro (+) iste<br>
                            â€¢ "p-ANCA pozitif ama MPO negatif?" â†’ Atipik ANCA, Ä°BH dÃ¼ÅŸÃ¼n<br>
                            â€¢ "Homojen ANA + dsDNA(-) + Histon(+)?" â†’ <strong>Ä°laca baÄŸlÄ± lupus</strong><br>
                            â€¢ "46 ayrÄ±k nokta IIF'de?" â†’ <strong>Anti-sentromer (CREST)</strong><br>
                            â€¢ "Crithidia luciliae ne iÃ§in?" â†’ <strong>Anti-dsDNA</strong> (en spesifik yÃ¶ntem)
                        </p>
                    </div>

                    <div class="alert-box alert-box--info">
                        <span class="alert-box__icon">ğŸ’¡</span>
                        <p class="alert-box__text"><strong>Pratik SÄ±nav YaklaÅŸÄ±mÄ±:</strong><br><br>
                            <strong>Soru:</strong> "55 yaÅŸÄ±nda kadÄ±n, ANA 1:320 homojen patern, eklem aÄŸrÄ±sÄ±..."<br>
                            <strong>DÃ¼ÅŸÃ¼n:</strong> Homojen = dsDNA veya Histon<br>
                            <strong>Ä°ste:</strong> Anti-dsDNA, Anti-Histon, C3, C4<br>
                            <strong>DeÄŸerlendir:</strong> dsDNA(+) + dÃ¼ÅŸÃ¼k kompleman = aktif SLE
                        </p>
                    </div>

                    <ul class="feature-list">
                        <li><b>Soru tipi:</b> "Homojen ANA + Anti-dsDNA (+)?" â†’ SLE</li>
                        <li><b>Soru tipi:</b> "Benekli ANA + Anti-SSA (+)?" â†’ SjÃ¶gren veya SLE</li>
                        <li><b>Soru tipi:</b> "NÃ¼kleolar ANA?" â†’ Skleroderma</li>
                        <li><b>Soru tipi:</b> "c-ANCA + sinÃ¼zit + hemoptizi + hematÃ¼ri?" â†’ GPA</li>
                        <li><b>Soru tipi:</b> "p-ANCA + RPGN?" â†’ MPA veya anti-GBM</li>
                        <li><b>Soru tipi:</b> "KaÅŸÄ±ntÄ± + ALP yÃ¼ksek + AMA (+)?" â†’ PBC</li>
                    </ul>
                `
            }
        ]
    }
];

// Global export
window.topicsData = topicsData;
